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Dynein is an essential motor protein required for the maintenance and survival of 
cells. Dynein forms a motor complex to carry intracellular cargoes like organelles, 
growth factors, peptides, and hormones along the microtubules inside the cells. 
In neurons, the dynein is the retrograde motor protein that moves cargoes from 
the neuronal tip to the neuronal soma along the length of an axon. Dynein has an 
established role in neuronal nuclear migration, transport of neuronal survival 
signals and growth factors, organelle positioning inside neurons etc. Hence, it is 
not very surprising that numerous mutations in dynein have been reported in 
association with neurodegenerative diseases in humans. The first human 
mutation (H306R) in dynein heavy chain was reported to cause Charcot-Marie-
Tooth Type 2O disease (CMT2O) in humans. CMT2O patients display motor-
sensory neuropathy symptoms such as muscle weaknesses and wasting in legs, 
skeletal deformities like pes cavus (high foot arching), difficulty in walking, and a 
loss of sensation. 
We developed a novel knock-in H304R mouse model with the corresponding 
CMT2O linked dynein mutation to understand the disease’s molecular 
mechanism. We investigated and characterized the motor-sensory phenotype of 
the H304R mouse model (wildtype, heterozygous (H304R/+) and homozygous 
(H304R/R) mice). First, we started with testing mice on motor skills behavior 
tests such as tail suspension reflex, grip strength test, and rotarod test at 3, 6, 9 
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and 12 months of age. Both male and female groups of heterozygous (H304R/+) 
mice displayed mild defects in tail suspension reflex, grip strength, and rotarod 
performance. In contrast, homozygous (H304R/R) mice exhibited severe defects 
in the tail suspension reflex, grip strength, and rotarod performance right from an 
early age. Next, I analyzed the sensory phenotype of the H304R mouse model. 
Homozygous H304R/R mice appeared to have thinner sciatic nerves, reduced 
total fascicular area of the sciatic nerve, and significantly quicker latency to tail 
withdrawal from a pain stimulus than the wildtype and heterozygous H304R/+ 
mice.  
Collectively, our motor and sensory characterization studies reveal that H304R 
dynein mouse model recapitulates many of the phenotypes associated with CMT 
symptoms. Hence, the H304R model is a useful tool in understanding the dynein 
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CHAPTER 1: INTRODUCTION 
Dynein is a motor protein present ubiquitously in many living organisms ranging 
from small microorganisms (yeast, fungi, parasite etc.) to humans. One of the 
many functions of dynein is to carry intracellular cargo on microtubule tracks 
(Paschal and Vallee, 1987). Microtubules are polarized cytoskeletal filaments 
that are usually arranged with their growing plus ends at the cell periphery and 
their minus ends at the microtubule-organizing center (MTOC) at the cell center. 
Dynein utilizes adenosine triphosphate (ATP) as an energy source to power its 
motor function and carries cellular cargoes from the cell periphery to the minus 
end of the microtubule at the cell center (retrograde). In contrast, the motor 
protein kinesin carries the cellular cargoes from the cell center to the plus end of 
the microtubule that is usually located at the cell periphery (anterograde).  
In eukaryotic cells, there are 3 classes of dynein – cytoplasmic dynein 1, 
cytoplasmic dynein 2, and axonemal dynein (Wickstead and Gull, 2007) (Yagi, 
2009). Cytoplasmic dynein 1 is involved in minus end directed transport within 
the cell body and has extensive cellular functions ranging from intracellular 
transport to cell division activities (listed in the Table 1-1). Cytoplasmic dynein 2 
acts as a motor protein inside cilia/flagella and is involved in intraflagellar 





Figure 1-1 Intracellular motility inside a cell 
Motor proteins dynein and kinesin carry cargoes like mitochondria and vesicles on the 
microtubule tracks. Dynein is minus end directed motor protein, while kinesin is plus end 
directed motor protein 
 
Cytoplasmic dynein 2 transports cargoes from the tip to the base of cilia where 
the minus end of microtubule is located (Porter et al., 1999). The axonemal 
dynein is integrated with the microtubule to make the core structure of cilia called 
axoneme (Gibbons and Rowe, 1965). Axonemal dynein is involved in powering 
the ciliary beating to make the cilia and flagella motile. Cytoplasmic dynein 1 will 
be referred just as ‘cytoplasmic dynein’ or ‘dynein’ from now on in this document. 
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1.1 Cytoplasmic Dynein Structure 
Dynein is a large multimeric protein complex that is ~1.2 megaDalton in size. A 
functional dynein motor unit (Figure 1.1) is comprised of many subunits – 1 pair 
of dynein heavy chains (DHC), 1 pair of dynein intermediate chains (DIC), 2 pairs 
of dynein light intermediate chains (DLIC), and 3 pairs of dynein light chains 
(DLC). The dynein heavy chain (DHC) monomers dimerize at the N-terminal to 
form a heavy chain dimer that interacts with other dynein subunits (DIC, DLIC, 
DLC) to form a functional dynein motor complex. 
Figure 1-2 Cytoplasmic Dynein Structure 
Dynein is a multimeric protein comprising of subunits - dynein heavy chain (DHC), 
dynein light intermediate chain (DLIC), dynein intermediate chain (DIC) and dynein light 










1.1.1 Cytoplasmic Dynein Heavy Chain Structure 
The cytoplasmic dynein heavy chain (DHC) is encoded by the gene dync1h1 and 
the peptide is ~532 kiloDalton in size. Cytoplasmic dynein heavy chain (DHC) 
gene - dync1h1 is an essential gene. Animals with homozygous dynein null 
mutations displayed embryonic lethality at embryonic day 8.5 where the embryo 
development couldn’t proceed past the gastrulation stage due to disruptions in 
Golgi trafficking and function (Harada et al., 1998). A single DHC monomer is 
4646 amino acids long peptide in humans and 4644 amino acids long in mice. 
The DHC can be divided into two main domains – N terminal tail domain and C 
terminal globular head domain (Figure 1.2). Two monomers of DHC 
homodimerize at the N-terminal tail region and interact with other subunits to 
form a single functional unit of dynein. The C terminal globular head has 6 
repeating AAA+ ATPase units forming a ring structure arrangement (Burgess et 
al., 2004) (Sakato and King, 2004).  
 
Figure 1-3 Cytoplasmic Dynein Heavy Chain (DHC) peptide 
Dynein heavy chain has two domains – N terminal tail domain and C terminal head 
domain. There are also six AAA ATPase domains (AAA1-AAA6) that make up the motor 
dynein ring. 
2
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The six ATPase rings domains (AAA1-AAA6) are responsible for the motor 
activity of DHC (Kon et al., 2012). Ring domain AAA1 has the p-loop motif that 
can bind and hydrolyze ATP to generate energy for dynein motor activity 
(Gibbons et al., 1991). Domains AAA2-AAA4 has p-loop motifs and ability to bind 
ATP, whereas domains AAA5-AAA6 lack ATP binding sites. Overall, domains 
AAA2-AAA6 lack ATP hydrolysis activity but do provide structural integrity and 
regulate functions of the dynein motor ring (Mocz et al., 1991) (Neuwald et al., 
1999). A coiled-coil ‘stalk’ region is located between AAA4-AAA5 in the motor 
ring and contains the microtubule binding domain (MTBD) of dynein heavy chain 
at its tip (Koonce, 1997). ‘Linker’ domain lies across the six ATPase rings and it 
changes its conformation based on the ATP binding state of dynein (Roberts et 
al., 2012). 
The cytoplasmic dynein undergoes a mechanochemical cycle where mechanical 
conformational changes and chemical transitions regulate the motor activity. A 
typical mechanochemical cycle of dynein consists of the following steps  
(Burgess et al., 2003; Imamula et al., 2007; Kon et al., 2005) - 
1. In the initial state, dynein is attached to the microtubule track via the 
microtubule binding domain (MTBD) in the stalk region. 
2. When an ATP molecule binds to the AAA+ ATPase domain of dynein 
heavy chain, the MTBD of the stalk detaches from the microtubule. 
3. Detachment of stalk from the microtubule causes a conformational change 
in the linker domain and linker gets rotated. 
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4. Upon ATP hydrolysis, MTBD of stalk binds to a new position on the 
microtubule and that leads to the release of ADP and Pi (inorganic 
phosphate molecule). 
5. Released Pi causes linker domain to straighten and generate a 
“powerstroke” that extends dynein tail along with its cargo to move further 
along towards the minus end of the microtubule track.  
1.2 Cytoplasmic Dynein Function 
Dynein has variety of roles and functions to play in a healthy functioning cell. 
Dynein is involved in both cell division and interphase activities of the cell. Dynein 
moves its cargoes on the microtubule in a “stop and go” manner. If the same 
cargo has dynein and kinesin attached to it, then the transport of the cargo can 
momentarily stop and the travel direction can get switched sometimes from the 
retrograde to anterograde direction inside the cell (Steffen et al., 1997). 
Sometimes the role of dynein is also distinct in different organisms – for example, 
dynein transports vesicles in filamentous fungi (Sivagurunathan et al., 2012) 
whereas dynein is responsible only for mitotic spindle positioning in yeast (Moore 
et al., 2009). Even viruses utilize dynein driven transport of endocytotic vesicles 
to reach the nucleus to replicate itself using the host machinery (Dodding and 
Way, 2011). These functions of dynein are broadly categorized and summarized 
in Table 1-1. 
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It is clear that cytoplasmic dynein is involved in many cellular functions that are 
essential for the cell growth, maintenance, and survival. Total loss of dynein 
function causes early embryonic lethality in Drosophila melanogaster (Dick et al., 
1996). Heterozygote dynein heavy chain knockout mice did not exhibit any 
phenotype, however, the dynein-null homozygous mice were embryonic lethal 
and did not survive past the gastrulation stage (Harada et al., 1998).  
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 Table 1-1 Cellular functions of cytoplasmic dynein 















Vesicles Transport of vesicles  (Sivagurunathan et al., 2012), 
(Koonce, 2000) 
Early endosomes Receptor sorting and Rab5 positive early 
endosome morphogenesis in HeLa cells 
(Driskell et al., 2007) 
Peroxisomes Coordinated movement of peroxisomes in 
cultured Drosophila melanogaster cells 
(Kural et al., 2005) 
Melanosomes Regulation of melanosomes transport in 
Xenopus melanophore cell line 
(Gross et al., 2002) 
Golgi vesicles Transport of vesicles from endoplasmic 
reticulum to Golgi in mammalian cell lines 
(Presley et al., 1997), 
(Hoogenraad et al., 2001) 
Mitochondria Transport of mitochondria in motor axons of 
Drosophila melanogaster and in neurons 




Rab7-interacting lysosomal protein (RILP) 
recruit dynein to Rab7 positive lysosomes and 
late endosomes in mammalian cells 
(Jordens et al., 2001),  
(Cantalupo et al., 2001),   
9 
 





















Phagosomes Dynein and dynactin regulate the maturation 
and minus end directed motility of phagosomes 
in mammalian cells 
(Blocker et al., 1997) 
Autophagosomes Maturation of autophagosomes (containing 
organelles and soluble proteins for targeted 
degradation) is regulated spatially by dynein in 
primary neurons 
(Maday et al., 2012) 
Aggresomes Dynein drives the misfolded protein into 
aggresomes for sequestration and eventual 
degradation 












Dynein positions nucleus in budding yeast 
Saccharomyces cerevisiae during cell division 
(Moore et al., 2009) 
Spindle 
positioning  
Cortical dynein pulls and displaces microtubules 
for mitosis and meiosis  
(McNally, 2013) 
Centrosomes Dynein transports and assembles gamma 
tubulin and pericentrin at the centrosomes for 
microtubule nucleation & organization 
(Young et al., 2000) 
Chromosome 
separation 
Dynein associated with the nuclear envelope 
drives separation of chromosomes in prophase 

























Nuclear rotation Dynein rotates and directs the nucleus in the 
leading edge of motile fibroblasts 
(Levy and Holzbaur, 2008) 
Microtubules Dynein maintains stable microtubule and 
kinetochore orientation for aligning 
chromosomes during metaphase 
(Varma et al., 2008) 
Neurofilaments Direct interaction and translocation of 
neurofilaments by dynein in neuronal cells 
(Shah et al., 2000) 
Transcription 
factors 
Retrograde transport of transcription factor such 
as glucocorticoid receptor from the cytoplasm to 
the nucleus 
(Harrell et al., 2004) 
Ribonucleoprotein  Correct mRNA localization by dynein mediated 
apical transport in Drosophila melanogaster 













HIV‐1 and HSV1 Dynein is hijacked by the viruses such as 
Human immunodeficiency virus type 1 (HIV‐1) 
and Herpes simplex virus (HSV1) to reach the 
nucleus of the host cells for replication 
(Dodding and Way, 2011) 
Adenovirus Adenovirus capsid hexon directly interacts with 
dynein for viral transport to the nucleus 
(Bremner et al., 2009) 
 
Category Cargo Cellular functions References 
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1.2.1 Dynein interactions with its binding partners 
There are three families of cytoskeletal motor proteins inside a cell – microtubule-
based dynein, microtubule-based kinesin, and actin-based myosin. Multiple 
subfamilies and isoforms of kinesins and myosin are available inside the cells to 
perform distinct cellular functions (Vale, 2003). However, dynein has only three 
classes inside the cell as mentioned previously – cytoplasmic dynein 1, 
cytoplasmic dynein 2, and axonemal dynein. Cytoplasmic dynein 2 and axonemal 
dynein are dedicated to ciliary and flagellar functions specifically. Therefore, 
cytoplasmic dynein 1 (referred as dynein from now on) is solely responsible for 
multiple cellular functions in all cell types besides cilia/flagella. It is no wonder 
that dynein utilizes and interacts with various adaptor proteins to carry out 
diverse cellular functions (Vallee et al., 2012). 
Binding of dynein with its interacting partners controls different cellular functions 
and is needed to load the cargo onto the motor complex. Dynein cargoes range 
from membranous vesicles, organelles, proteins, cytoskeletal components and 
even viruses. Furthermore, an active motor complex facilitates varied dynein-
based functions such are organelle transport and positioning (Burkhardt et al., 
1997), mitotic chromosome separation (Dujardin et al., 1998), and nuclear 
migration (Levy and Holzbaur, 2008). Dynein interacts with many intracellular 
binding partners via direct or indirect interactions (Figure 1-4). DHC participates 
in the catalytic motor activity and other dynein subunits like LCs, ICs, LICs 
12 
 
interact with adaptor proteins to regulate various dynein functions in the cell 
(Pfister, 2015).  
The direct binding partners of dynein include nuclear distribution protein E 
(NudE) (McKenney et al., 2011), lissencephaly (LIS 1) (Huang et al., 2012), 
dynactin (dA) (Schroer, 2004), RAB-interacting lysosomal protein (RILP) 
(Schroeder et al., 2014), Huntingtin protein (Htt) (Caviston and Holzbaur, 2009), 
Snapin on late endosomes (Cai et al., 2010), adenoviral hexon protein (Bremner 
et al., 2009), and pericentrin centrosomal protein (Tynan et al., 2000). 
Dynactin regulates dynein driven motility by enhancing dynein’s binding with the 
microtubule and making the transport more processive (Culver-Hanlon et al., 
2006). Additionally, dynactin also acts as an cargo adaptor for dynein and helps 
dynein link with multiple cargo adaptors such as - Ankyrin 2 (AnkB) on 
membranous cargoes (Lorenzo et al., 2014), RILP on Rab7 positive late 
endosomes (Jordens et al., 2001), c-Jun N-terminal kinase-interacting proteins 
(JIPs) on neuronal cargoes (like amyloid precursor protein) (Fu and Holzbaur, 
2013), Huntington-associated protein 1 (HAP1) on neuronal vesicles (Engelender 
et al., 1997), Spectrin on Golgi vesicles & late endosomes/lysosomes (Holleran 
et al., 1996), bicaudal D/BICD2 on Golgi-ER vesicles (Liu et al., 2013; Matanis et 














Figure 1-4 Binding partners of dynein 
Dynein interacts with various cargo adaptors either directly (shown in blue arrows) or indirectly (shown in orange arrows) to 
achieve versatility in its cellular functions. Dynein heavy chain (DHC), dynein light intermediate chain (DLIC), dynein 






Dynactin BicD, RILP, JIP, HAP1, AnkB, Spectrin, TRAK/Milton 
Adenoviral hexon protein, pericentrin, RILP, 
NudE/NudEL Lis1 
Lis1 
DIC Htt, Snapin 
Direct interaction with dynein 
Indirect interaction with dynein 
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1.2.2 Dynein mutations linked to neurodegeneration in humans 
Neurons are highly polarized cells with axonal projections as long as up to a 
meter in length. Consequently, it is understood that neurons need robust axonal 
transport for survival. Dynein has an established role in retrograde transport of 
cargoes from the neuronal tip to soma in neurons (Perlson et al., 2010). 
Additionally, dynein interacts with dynactin to form a highly processive motor 
complex (Culver-Hanlon et al., 2006) that has an important role in axonal 
transport (Waterman-Storer et al., 1997). The dynein/dynactin motor protein 
complex transports cargo from the tip of the axon towards the neuronal cell body 
(retrograde direction). Other functions of dynein in neurons includes growth and 
development of neurites (Barakat-Walter and Riederer, 1996), formation of 
synapse in neurons (Cheng et al., 2006), axonal transport of microtubules & 
neurofilaments (He et al., 2005) and intracellular organelles (Schnapp and 
Reese, 1989), and neuronal migration inside the cortical layer of the brain 
(Sasaki et al., 2000).  
Seeing how crucial dynein is for neuronal growth and maintenance, it would not 
seem very surprising to see a dynein heavy chain mutation leading to 
neuropathies in humans (figure 1-5). The first dynein heavy chain mutation 
H306R was reported in 2011, that lead to a hereditary motor-sensory 
neurodegenerative disease called Charcot Marie Tooth Disease Type 2O in 
humans (Weedon et.al. 2011). Since then at least 17 genetic mutations spanning 
the motor and tail domains of the dynein heavy chain have been identified in 
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neurodegenerative diseases in humans (summarized in Table 1-2). The reported 
dynein heavy chain mutation related diseases in humans can be broadly 





Figure 1-5 Mutations in Dynein Heavy Chain (DHC) 
Mouse mutations (top, in blue text) and human mutations (bottom, in red text) in the DHC peptide. Mice mutations are 





Table 1-2 Dynein heavy chain mutations in humans 
Disease DHC mutation Clinical symptoms Reference 
Charcot Marie Tooth 
Type 2O (CMT2O) 
H306R muscle weakness and wasting, gait 
abnormalities, skeletal deformities, 
motor milestone delays, loss of 
sensation 
(Weedon et al., 
2011) 
Spinal Muscular Atrophy 
– Lower Extremity 
Dominance (SMA-LED) 
I584L, K671E, Y970C, 
G1132E 
Severe muscular atrophy in legs, 
loss of motor neurons, delay in 
motor milestones, waddling gait 
(Harms et al., 
2012)  
Malformation of Cortical 
Development  
deletion 659-662, K129I, 
K3336N, R3384Q, R1567Q, 
R3344Q, R1962C, K3241T, 
R3344Q 
Neuronal migration defects in 
cerebellar cortex, microcephaly or 
macrocephaly, polymicrogyria, 
epilepsy/seizure in severe cases 




Disease DHC mutation Clinical symptoms Reference 
Intellectual disability E1518K, H3822P Defects in neuronal migration, 
cortical development malfunctions, 
impaired speech, reduced 
intellectual and mental functions, 
gait problems 
(Willemsen et al., 
2012) 
Congenital cataracts and 
gut dysmotility 
R2332C Cataract at birth, oral dysphagia, 
dysmotility in gut, developmental 
milestone delay, bifrontal 
polymicrogyria 
(Gelineau-Morel 






It is interesting to note that even though these mutations lie in the same DHC 
gene, they result in different clinical manifestations in humans. The DHC motor 
domain mutations generally lead to cortical development type of defects, 
whereas, the DHC tail domain mutations were observed to cause motor-sensory 
type of defects in the reported human neuropathies. Moreover, it is important to 
note that all dynein mutations in humans exhibit symptoms that are heavily 
related to neuronal defects rather than any other type of defects in humans. This 
suggests that dynein must have a specialized role in the neurons because even 
the smallest single point mutation in dynein can disrupt the regular functions of 
the central or peripheral nervous system. Hence, it is evident that mammalian 
neurons must be particularly sensitive to the dynein mutations.  It would be 
valuable to understand how dynein heavy chain mutations cause diseases 





1.3 Charcot-Marie-Tooth Diseases in Humans 
Charcot-Marie-Tooth (CMT) disease is the most common type of hereditary 
motor-sensory neuropathy in humans with estimated prevalence rate is 1 in 2500 
humans. CMT is characterized by symmetric distal limb weaknesses, muscular 
atrophy in hands and/or feet, loss of sensation in lower limbs that may lead to 
foot ulcerations, and skeletal defects like pes cavus (high arching of feet) (Figure 
1-6).  
More than 80 genes that are involved in neuronal structure maintenance signal 
transduction, and axonal transport are reported to have mutations that are linked 
with CMT (Bird, 1993). CMT patients are categorized into different types (table 1-
3) based on their nerve conduction velocity (NCV) and family history-based 
inheritance of the disease. In each category, letters are assigned to represent the 
gene involved. For example – CMT1A, CMT1B, CMT1C and so on, CMT2A, 
CMT2B, CMT2C and so on. CMT1A indicates CMT Type 1A which is caused by 
a mutation in PMP22 gene (myelination gene) (Patel et al., 1992) whereas 
CMT1B indicates CMT Type 1B which is caused by a mutation in MPZ gene 
(another myelination gene). 
CMT is clinically diagnosed by molecular genetic testing and by identifying 
peripheral neuropathy symptoms during their physical examinations and in their 
previous medical history. CMT has a variable onset in patients, ranging from as 
early as age at birth to as late as age 50. Currently there is no cure for CMT, and 
the treatment is based on the clinical symptoms presented by the patients. CMT 
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patients often have to rely on surgical treatments, physical therapy, and use of 
prosthetics like crutches/ankle braces to cope with the symptoms. About 5% of 
all CMT patient are dependent on wheelchair for mobility. 
Another challenge with CMT is the heterogeneity of the disease onset, 
progression, and clinical symptoms even in related patients from the same family 
pedigree. For example- in the Dominant Intermediate Charcot-Marie-Tooth 
disease (DI-CMT), some patients from the same family may show demyelination 
associated symptoms, whereas other patients from the same family may show 
axonal degeneration, and some may even show both demyelination and axonal 
demyelination form of the CMT symptoms. 
 
Figure 1-6 Clinical symptoms associated with Charcot Marie Tooth (CMT) 
CMT patients primarily show distal lower limb muscle wasting and atrophy, foot 




Table 1-3 Types of Charcot-Marie-Tooth disease in humans 
Type of CMT Type of defect Inheritance Some examples of mutations (Bird, 1993) 
CMT Type 1 
(most common) 
Demyelination with 
reduced NCV of <35m/s 
Autosomal 
dominant 
PMP22, MPZ, LITAF, ERG2, NEFL 




MFN2, RAB7, TRPV4, GARS, NEFL, MPZ, 




Demyelination and axonal 




GDAP1, MPZ, DNM2, DRP2, GNB4, INF2, 
PLEKHG5, YARS,  
CMT Type 4 
(rare) 
Demyelination and axonal 




GDAP1, MTMR2, SBF2, SH3TC2, NDRG1, 
EGR2, PRX, FGD4, FIG4, HINT1 
CMT Type X Demyelination and axonal 
degeneration with NCV of 
35-45m/s  




1.3.1 Dynein mutation linked to CMT2O and SMA-LED 
A dynein heavy chain mutation linked to Charcot-Marie-Tooth type 2O (CMT2O) 
in humans was first identified in 2011 (Weedon et al., 2011). Exome sequencing 
of genes in a four generation European family identified a single point missense 
substitution of Histidine to Arginine at position 306 (H306R) in cytoplasmic dynein 
heavy chain 1 peptide (figure 1-7). The autosomal dominant H306R mutation 
affected 23 members (male and female) in this family and they showed a varied 
range of clinical symptoms. 
 
Figure 1-7 CMT2O and SMA-LED linked mutation in dynein heavy chain 
Missense substitution mutation (Histidine to Arginine) at position 306 in human 
cytoplasmic dynein heavy chain peptide has been linked to two distinct neuropathies – 
Charcot Marie Tooth type 2O (CMT2O) and spinal muscular atrophy with lower extremity 
dominant (SMA-LED).  
 
CMT2O patients with autosomal dominant heterozygous H306R mutation have 
varied disease onset ranging from early childhood to early adulthood. CMT2O 
patients reportedly had delayed motor developmental milestones, problems in 
walking or running, recurrent falls, slow progressing muscle weakness and 
muscle wasting in lower legs, and skeletal deformities pes cavus (high arching of 
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foot). Physiological tests with CMT2O patients revealed normal nerve conduction 
velocities, evidence for axonal degeneration in sural nerve biopsies, and 
denervation defects in muscle biopsies. Several patients that were severely 
affected with CMT2O also reported to have neuropathic pain and prickling 
sensation (paresthesia) in their lower limbs. A few patients also reported loss of 
reflexes and sensation, speech delays & behavioral problems, lumbar lordosis, 
spinal and hip issues leading to waddling gait, and loss of proximal muscles in 
the upper back (periscapular weakness). 
In parallel, an independent study of a Japanese family with the same H306R 
mutation presented clinical symptoms that were consistent with spinal muscular 
atrophy with lower extremity dominant (SMA-LED) (Tsurusaki et al., 2012). The 
patients in this family showed clinical features that were different from CMT2O 
patients, such as proximal lower limb weakness instead of distal limb weakness 
and non-progressive nature of muscular atrophy/wasting. SMA-LED patients with 
H306R mutation showed motor neuron disease involvement but not sensory 
neuron involvement. It is interesting to note that a family member in the 
European family with CMT2O showed proximal limb atrophy like SMA-LED 
patients in this Japanese family. In conclusion, the single point mis-sense 
substitution of H306R in cytoplasmic dynein heavy chain has been reported to 
cause to two separate neuropathies in humans – CMT2O and SMA-LED. 
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1.4 Mouse Models with Neurodegeneration Linked Dynein Mutations 
There are three reported mouse models with DHC mutations – Legs at odd 
angles (Loa), Cramping (Cra), Sprawling (Swl) (figure 1-8). These mice were 
named after their abnormal hind limb clenching phenotype and their posture. 
Heterozygotes of all three mouse models had normal lifespan, whereas the 
homozygotes showed severe phenotype & did not survive embryonically or after 
birth (Chen et al. (2007); (Hafezparast et al., 2003).                                                                       
Loa and Cra mice were generated independently via N-ethyl-N-nitrosourea 
(ENU) treated mice and were identified due to abnormal clenching of hind limbs 
when lifted by tail (Hrabe de Angelis et al., 2000). Swl was created via radiation-
induced mutagenesis, also displayed abnormal clenching of hind limbs (Duchen, 
1974). All three Loa, Cra, and Swl are autosomal dominant mutations that lead to 
neurodegenerative phenotypes. Loa/+ and Cra/+ developed late-onset of motor 
neuropathy, whereas Swl/+ showed early-onset of hereditary sensory 
neuropathy. The key features of the three DHC mutant heterozygous mice are 






Figure 1-8 Dynein heavy chain (DHC) mutations in mice 





Table 1-4 Dynein heavy chain mutations in mice 
DHC mutation Phenotype 
Legs at odd angles (Loa) – 
F580Y 
(Hafezparast et al., 2003) 
 
 Loa/Loa homozygous lethal 
 late-onset motor neuron  
degeneration in Loa/+ 
 gait abnormalities 
 reduced front and hind limb strength, 
 thinner dorsal root and sciatic nerve 
 abnormal proprioception & absence of 
H-reflex 
 lumbar DRG neurons loss 
 mild loss of spinal α- motor neurons 
 muscle spindle loss 
 neuronal migration defects 
Cramping (Cra) – Y1055C 
(Hafezparast et al., 2003) 
 Cra/Cra homozygous lethal 
 late-onset sensory neuron 
degeneration in Cra/+ 
 gait abnormalities 
 reduced hind limb strength 
 thinner dorsal root 
 abnormal muscle pathology, 
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 mild loss of spinal α- motor neurons 
 behavioral hyperactivity 
 mitochondrial dysfunction in skeletal 
muscles 
Sprawling (Swl) – 
[GIVT]1040[A] 
(Chen et al., 2007) 
 Swl/Swl homozygous lethal  
 early-onset hereditary sensory 
neuropathy in Swl/+ 
 gait abnormalities 
 reduced hind limb strength, 
 thinner dorsal root and sciatic nerve 
 abnormal proprioception & absence of 
H-reflex 
 lumbar DRG neurons loss 
 muscle spindle loss 
 
To better understand the role of dynein in neurodegeneration, Loa/+, Cra/+, and 
Swl/+ heterozygote mice were separately cross bred with the mutant SOD1G93A 
mouse model of amyotrophic lateral sclerosis (ALS). ALS is a fast progressing 
neurological disease marked by progressive loss of motor neurons, leading to a 
total paralysis and lethality 3-5 years after onset. The gain of function mutation 
G93A in superoxide dismutase 1 (SOD1) is autosomal dominant and kills motor 
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neurons rapidly (Valentine et al., 2005). It was interesting to note that when Loa/+ 
and Cra/+ were crossed separately with ALS SOD1G93A mice, their double 
heterozygotes pups showed attenuation of the ALS SOD1G93A symptoms and 
improved lifespan (Kieran et al., 2005) (Teuchert et al., 2006). This was a very 
unsuspected finding and opposite of what was expected at the time. Loa/+ and 
ALS SOD1G93A double heterozygotes also showed a remarkable increase in its 
retrograde axonal transport. Swl/+ and SOD1G93A heterozygotes did not show any 
attenuation or improvement of ALS SOD1G93A associated phenotype. It is 
interesting to note that even though not all three mutations lie in the same tail 
region of DHC, their attenuation response to ALS mutant SOD1G93A was the 
same. 
Undoubtedly, the three dynein heavy chain mutant mice (Loa, Cra, Swl) provided 
many key insights into understanding the dynein function in neurodegenerative 
disorders. However, Loa, Cra, and Swl mutations are not linked to any disease 
alleles in humans and it is difficult to correlate their findings to human 
neuropathies. Nevertheless, it would be very interesting to compare Loa, Cra, 
and Swl mice studies with other DHC mice models that have dynein mutations 
linked to an actual human disease.  
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1.5 Peripheral Nervous System of Mouse 
The peripheral nervous system of mouse comprises of nerves and ganglia 
arising out of the spinal cord. The dorsal root ganglia (DRG) is a cluster of 
sensory neuron cell bodies located in pairs in the spinal column of mice that start 
forming in the embryo at embryonic day 13 (E13) (Lawson and Biscoe, 1979). 
The sensory neurons located in the DRGs are pseudo-unipolar in nature and do 
not have dendrites. The DRG sensory neurons have a single axonal projection 
that branches into two – peripheral and central branches (figure 1-9). The 
peripheral branch brings in the nerve impulses from the innervated tissues (skin 
or muscle) to the neuronal cell body located in the DRG. The central branch 
carries the impulse away from the soma to the central nervous system i.e. the 
spinal cord or brain. Both branches are myelinated and carry the nerve impulses 
towards the central nervous system (shown by the arrows in figure 1-9). 
 
Figure 1-9 Pseudo-unipolar sensory neurons in DRGs 
Sensory neurons in the Dorsal Root Ganglia (DRG) are pseudo-unipolar in nature, i.e. it 




1.5.1 Role of dynein mediated retrograde signaling in sensory neurons 
Growth and maturation of sensory neurons inside the DRGs are dependent on 
various neurotrophic factors such as nerve growth factor (NGF), glial derived 
neurotrophic factors (GDNF), brain derived neurotrophic factors (BDNF), and 
neurotrophins (NTs)  (Kimpinski et al., 1997) (Markus et al., 2002) (Klusch et al., 
2018). The neurotrophic factors are secreted by the target tissue (muscle, skin, 
or visceral organ) and stimulate the development and function of sensory 
neurons (figure 1-10).  
 
Figure 1-10 Neurotrophic factors in sensory neurons development 
Sensory neurons and motor neurons growth, maturation and survival depends on the 
neurotrophic factors such as neurotrophins (NTs) and glial derived growth factors 
(GDNF) released by the target tissue they innervate. 
 
The neurotrophic factors bind to the tyrosine kinases (Trk) receptors located on 
the axonal terminals of the peripheral branch of the sensory neuron (table). NGF 
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specifically binds to TrkA receptors, NT4 and BDNF specifically bind to TrkB 
receptors, and NT3 specifically binds to the TrkC receptors (figure 1-11).  
 
 
Figure 1-11 Neurotrophic factors activate Trk signaling in neurons 
Neurotrophic factors bind to a specific Trk receptor and activate downstream signaling of 
neuronal maintenance and survival factors. NGF= Nerve Growth Factor, BDNF= Brain 
Derived Neurotrophic Factors, NT3/4= Neurotrophins 3/4.  
 
Binding of neurotrophic factors leads to dimerization of the receptors and their 
autophosphorylation that recruits the effectors for downstream Trk signaling. The 
activated Trk signals send survival factors such as mitogen-activated protein 
kinase (MAPK); phosphatidylinositol 3-kinase (P13K); phospholipase (PLC-γ) 
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etc. (Chao, 2003) (Delcroix et al., 2003) to the neuronal cell body located in the 
DRG via dynein mediated retrograde transport (Heerssen et al., 2004) (Ito and 
Enomoto, 2016).  
Neurotrophin mediated retrograde signaling also facilitates differentiation and 
specification of neuronal subpopulations in the peripheral nervous system of 
mice. Studies with BAX-/- and TrkA-/- double mutant mice lacking the NGF 
mediated TrkA signaling showed an absence of calcitonin gene related peptide 
(CGRP) expressing neuronal subpopulation in the mice DRGs (Suzuki et al., 
2010). Other studies have explored and established the role of target derived 
neurotrophic factors (such as neurotrophins & BDNF) in determining the 
cholinergic/peptidergic phenotype of the sensory neurons during their 
development and differentiation in mice (Bergmann et al., 1997; Cellerino et al., 
1996). 
Several in vitro studies have investigated and established the role and 
importance of retrograde transport of neurotrophic factors. Neurotrophic factors 
released by the target tissues bind to the specific receptors in the terminal ends 
of the sensory axons innervating the tissue. Then the neurotrophic factors 
mediated signaling cascade is activated at the axonal tip and it travels all the way 
to the neuronal cell body in retrograde fashion.  
Classical experiments with special compartmentalized cell chambers called 
Campenot chambers were performed to investigate the spatial effect of 
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neurotrophin Nerve Growth Factor (NGF) on axonal growth (Campenot, 1977). 
First, NGF was only supplied selectively to the compartment in the Campenot 
chamber that had distal ends of axons growing in it. It was observed that axonal 
growth was maintained even though the neuronal cell bodies did not receive 
NGF. However, when the NGF was applied only to the Campenot compartment 
containing neuronal cell bodies, the distal axons started retracting and 
degenerating. These key experiments established that NGF mediated 
neurotrophin signaling at the distal ends of neurons were required and adequate 
for axonal growth and maintenance. 
Subsequent studies then established that neurotrophins bound to the receptors 
are internalized and packaged inside signaling endosomes for retrograde 
transport to the neuronal cell bodies (Wang et al., 2016). Further investigation of 
retrogradely transported signaling endosomes in rat sciatic nerves revealed that 
these vesicles contained not only neurotrophin NGF and its receptor TrkA, but 
also characteristic markers of early endosomes such as early endosome antigen 
1 (EEA1) and Rab5 (small G-protein) (Deinhardt et al., 2006). Additionally, 
components of mitogen-activated protein kinase (MAPK) and phosphatidylinositol 
3-kinase (P13K) pathways were also found inside the signaling endosomes. The 
same study also showed the evidence of dynein dependent retrograde transport 
of these NGF-TrkA containing endosomes by colocalization, biochemical, and 
nocodazole microtubule disruption assays. Several other independent studies 
have also established the role of dynein in retrograde transport of neurotrophic 
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factors – colocalization of 14kDa Dynein Light Chain (DLC) with Trk receptors 
(Yano et al., 2001), Rab7 positive vesicles in NGF-TrkA signaling (Saxena et al., 
2005), and p75 and TrkB signaling (Deinhardt et al., 2006). 
In conclusion, dynein dependent retrograde signaling is necessary for the 
development, specification and maintenance of sensory neurons and it is not 
surprising that dynein disruption could cause sensory neuropathies. Numerous 
studies have shown that disrupted neurotrophic factor mediated Trk signaling 
causes severe sensory neuropathies in mice (Smeyne et al., 1994) (Patel et al., 
2000) (Sleigh et al., 2017).  
 
1.5.2 Sciatic Nerve anatomy in mice 
The sciatic nerve is the largest nerve innervating the hind limbs of mice. The 
sciatic nerves arise from the sciatic notch near the spine, then continues all the 
way from lumbosacral region to popliteal fossa (knee cavity) where it splits into 
peroneal, sural and tibial nerves to innervate the lower hind limbs in mice (figure 
1-12). The majority of sciatic nerves in C57BL/6J strain mice are made up of the 
third lumbar (L3) and fourth lumbar (L4) spinal nerves and a lesser contribution is 
received from the fifth lumbar (L5) spinal nerve (Rigaud et al., 2008). The 
percentage contribution from each spinal nerve in a sciatic nerve is roughly about 
L3 (~28%), L4 (~56%) and L5 (~16%) and no spinal nerve contribution is 




Figure 1-12 Sciatic nerve anatomy in mice 
Spinal nerves arising from lumbar vertebrae L3, L4, and L5 combine together to form a 
sciatic nerve in mice that splits up into peroneal, tibial, and sural nerves to innervate the 
lower hind limbs. 
 
Because the sciatic nerve contains both motor and sensory neurons, it is also 
regarded as a “mixed nerve” (Figure 1-13). Dorsal root supplies the sensory 
neurons (afferent fibers) and ventral root (efferent fibers) supplies the motor 
neurons at lumbar L3, L4, and L5 in mice to make up the “mixed” sciatic nerve in 
mice. The sensory nerves bring in the afferent sensing signals from the periphery 
target tissue to the spinal cord for processing. Sensing signals can be sensing 
temperature, pain stimulus, touch, vibrations etc. In contrast, the motor neurons 
send out the efferent action signals from the spinal to the target tissues. Action 
signals can be voluntary or involuntary action of a muscle group to a stimulus. 
Knee jerk test is a classic example of a reflex arc where the reflex hammer hits 
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the knee (stimulus) and the body reacts quickly by moving your leg away (action) 
through rapid involuntary muscle contraction. 
  
Figure 1-13 Sciatic nerve is a mixed nerve 
Sciatic nerve has both sensory and motor neurons and is called a “mixed nerve”. Both 
dorsal and ventral roots supply spinal nerves to make up the sciatic nerve. 
 
1.5.3 Dorsal Root Ganglia anatomy in mice 
Neural crest migration gives rise to a cluster of sensory neurons called dorsal 
root ganglia (DRG). There are 62 DRGs in total and they are located in pairs 
along the spinal cord – 8 pairs in cervical, 13 pairs in thoracic, 6 pairs in lumbar 
and 4 in sacral region in the C57BL/6J strain of mice (Malin et al., 2007). There 
are many types of heterogeneous somatosensory neuronal subpopulations 
present in the DRGs- nociceptors, mechanoreceptors, thermoreceptors, and 
proprioceptors (table 1-4). Somatosensory neurons transmit sensory signals to 
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the spinal cord and brain from the target tissues that they innervate such as 
muscle spindles, skin, and organs (Liu and Ma, 2011). 
Table 1-5 Major types of somatosensory neurons in the DRG 
Type of the neuron Size of the fiber Stimulus received 
Nociceptors Small diameter (c-fibers) Pain stimulus 
Mechanoreceptors Medium diameter (Aδ-
fibers) 
Pressure, touch and 
vibration 
Thermoreceptors Small diameter (AΔ-fibers) Temperature (cold 
and warm) 
Proprioceptors Large diameter (Aβ-fibers) Muscle stretch and 
orientation 
 
Different somatosensory neurons express different types of receptor. Nociceptive 
neurons have small sized diameter axons and express the TrkC receptors for 
Nerve Growth Factor (NGF) (Suzuki et al., 2010). In addition, peptidergic 
nociceptive neurons express calcitonin gene-related peptide (CGRP), whereas, 
non-peptidergic nociceptive neurons express IsolecithinB4 (IB4) on its plasma 
membrane (Bennett et al., 1996). Chemical stimuli such as capsaicin have been 
reported to also stimulate responses in nociceptors expressing capsaicin 
receptors called  transient receptor potential cation channel subfamily V member 
1 (TRPV1) channels (Amaya et al., 2004). Proprioceptive neurons have large 
39 
 
sized diameter axons and express TrkC receptors for neurotrophin 3 (NT-3) 
uptake. 
It is highly common for researchers to investigate the neuronal subpopulations in 
the DRGs of mice exhibiting any sensory neurodegenerative symptoms. For 
example - in sprawling (Swl) mice, it was reported that the heterozygous Swl/+ 
mice showed specific loss of its proprioceptive neurons and not in the nociceptive 
neuron population in the lumbar dorsal root ganglia (Chen et al., 2007). As a 
result, Swl/+ mice showed the corresponding phenotype of early-onset of 
proprioceptive sensory neurological defects. In conclusion, investigation of sciatic 
nerve anatomy and DRG neuronal subpopulation can provide key insights in 
understanding molecular mechanisms behind sensory neuropathies.  
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Generation of H304R mouse model 
The knock-in H304R mouse model was generated using gene targeting in mouse 
embryonic cells (figure 2.1). Using 3-step PCR mutagenesis, the CMT2O disease 
linked dynein mutation (CAC to CGC at position 304) was introduced in the 
targeting vector with Neo cassette. Presence of the mutation was confirmed by 
sequencing the PCR amplified targeted region. Then embryonic stem cells were 
electroporated to take in the targeting vector. Embryonic stem cell clones with the 
correct targeted single point mutation were confirmed using resistance selection 
markers, PCR screening, and southern blot analysis. The embryonic stem cells 
were then microinjected in C57BL/6 mouse blastocysts and implanted into 
psuedopregnant foster host female mice. The offspring chimeric mice were 
obtained, and cross bred to yield the heterozygous knock-in founder mice. Four 
heterozygous founder mice with the desired single point mutation in dynein 
heavy chain were outcrossed with B6129SF2/J mice (Jackson laboratories) to 
produce a colony of different lineages. Heterozygous male and female mice from 




Figure 2-1 Generation of knock-in H304R mouse model 
Knock-in H304R mouse model was generated by introducing Neo cassette flanked 
targeting vector that was microinjected into embryonic stem cells. Chimeric mice were 




2.2 Mouse colony maintenance 
2.2.1 Mouse colony housing  
All mice related procedures were carried out with the University of Central 
Florida’s Institutional Animal Care and Use Committee (IACUC) guidance and 
approval. The mice were checked daily by the trained vivarium staff and were 
immediately treated in case of any health issues. Mice were housed in clear 
plastic cages lined with sanitized bedding and were provided ad libitum access to 
clean food and water. Mice cages were also provided with red colored housing 
tube and a wooden block for enrichment of their surroundings. The cages were 
kept in an environment-controlled room at 22 ± 2 °C and atmospheric humidity of 
50 ± 10%. Mice were exposed to artificial light from 7:00am-7:00pm and to 
darkness at 7:00pm-7:00am on a 12-hour diurnal light cycle. 
2.2.2 Mouse colony breeding 
Heterozygous H304R mice were repeatedly outcrossed to the B6129SF2/J mice 
(Jackson Laboratories, stock#101045). Mice pups remained with their mother for 
nursing until they were weaned on post-natal day 21 (3 weeks of age). Tail snips 
were collected from the 3-week old pups upon weaning for PCR based 
genotyping. Mice tails were also tattooed with unique identification numbers 




2.2.3 Measurement of mouse body weight  
Body weight of a mouse was recorded (in grams) every 2 weeks before the 
mouse performed a behavior test. Bodyweight at 3 month of age were 
statistically compared between the genotypes (wildtype, heterozygous, 
homozygous) and gender (male and female) separately using One-way ANOVA 
(GraphPad Prism 6.0 software).  
2.2.4 Mouse health supervision 
Mice colonies were kept under daily supervision of trained vivarium staff in case 
any medical condition would arise. Mice were regularly monitored for their 
posture, alertness, activeness, movement around their cages and consumption 
of food and water. Physiological phenotypes of mice such as blood in urination, 
and abscess on skins due to excessive scratching were immediately treated and 
closely monitored. Mice teeth were routinely trimmed if they showed weight loss 
due to inability to feed with longer teeth. 
Other litter behaviors like fights with littermates, barbering each other, and 
shredding of food were also noted. Phenotype like development of eye tumors, 
recurrent seizures, and worsening health were also recorded. We immediately 
euthanized any mice that showed any signs and symptoms of pain, suffering, 




2.3 Behavioral phenotype characterization test 
All three groups of mice (wildtype, heterozygous H304R/+, homozygous 
H304R/R) performed behavioral tests every two weeks starting from 1 month of 
age to 24 months of age or until death (whichever came first).  Later time points 
such as 15, 18, 21 and 24 months of the longitudinal study yielded similar 
phenotypic trend in mice at 12 months of age. Hence, the test readings until 12 
months only were averaged in a 3-month bin to give time points of 3 month, 6 
month, 9 month, and 12 month for data analysis.  
The behavior assay data was collected by the researchers that were blinded to 
the genotype of the H304R mice. Mice were genotyped by other lab members 
and the mice genotypes were revealed after the completion of the study for data 
grouping and statistical analyses. Both testers alternated their turn in testing the 
same test mouse every two weeks. The behavior tests - tail suspension, grip 
strength, rotarod, and tail flick tests were performed on all three groups of H304R 
mice (wildtype, heterozygous, homozygous) as described below. 
 
2.3.1 Tail suspension test 
The tail suspension test was performed to assess the postural reflex phenotype 
of mice. A mouse was gently lifted by its tail and its positioning of hind limbs were 
categorized as 'typical' or 'atypical' tail suspension reflex. In a 'typical' tail 
suspension reflex (figure 2-2), the mouse splayed its hind limbs away from the 
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body after being suspended by its tail. Whereas, in 'atypical' tail suspension 
reflex, the mouse clenched its hind limbs tightly near its body when suspended 
by its tail. The data was collected and recorded from two views (ventral and 
dorsal) of the mice to get a better evaluation of the phenotype. 
 
Figure 2-2 Tail suspension test 
Mouse is gently suspended by its tail and the hind limb response is categorized as 
typical (shown here) or atypical (hind limbs clenching together). 
 
The percentage of mice displaying ‘atypical’ reflexes was calculated for all three 
groups of mice (wildtype, heterozygous, homozygous) at each time point - 3, 6, 
9, and 12 months. Then the ‘atypical’ reflex data were statistically compared 
between the wildtype and heterozygous H304R/+ and between wildtype and 
homozygous H304R/R mice at each time point using the Fisher’s exact test (two-
tailed distribution, p<0.05) on the GraphPad Prism 6.0 software. 
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2.3.2 Grip strength test 
A standard grip test was used to measure the muscular limb strength in mice 
using a grip strength meter from Harvard Apparatus (BIOSEB GS3# 76-1068). All 
limbs or front limbs of mouse were placed on the metal grid attached to the 
readout equipment. Then the mouse was gently pulled across the metal grid 
using its base of the tail. The equipment recorded the maximum force exerted (in 
grams) by the all limbs or front limbs of the mouse being tested (figure 2-3).  
 
Figure 2-3 Grip strength test meter 
Grip strength in limbs is measured using a standard grip strength meter that records the 
maximum force exerted by the mouse. 
 
A test mouse performed 4 consecutive trial each of all limbs and front limbs grip 
test. The 4 trials were averaged for all limbs and front limbs respectively to yield 
one single readout each on a test day. Next, the averaged all limbs grip strength 
readings and the averaged front limbs grip strength readings of a mouse were 
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combined per each genotype at 3-month time intervals - 3, 6, 9, and 12 months. 
The all limbs and front limbs grip strength data were statistically compared 
between the wildtype and heterozygous H304R/+ and between wildtype and 
homozygous H304R/R mice at each time point using Student’s t-test (two-tailed 
distribution, p<0.05) on the GraphPad Prism 6.0 software.  
2.3.3 Rotarod performance test 
Rotarod test is a standard test used to measure motor coordination, muscle 
endurance, and motor balance in mice. We performed rotarod test on our 
wildtype, heterozygous, and homozygous mice cohorts using rotarod equipment 
from IITC Life Sciences (model# 755). The optimized test parameters were input 
into the equipment console and 5 mice were placed individually on a stationary 
rod inside 5 different lanes before the start of the test (figure 2-4).  
 
Figure 2-4 Rotarod machine to measure motor coordination 
Motor coordination in mice is measured by the rotarod performance test. Five 




The rotarod started rotating at 5 RPM (Revolutions Per Minute) and gradually 
ramped up to 40 RPM in 60 seconds and stayed constant for next 120 seconds 
(figure 2-5). The entire run duration of rotarod was 180 seconds including 60 
seconds of ramp time followed by 120 seconds of constant RPM. The equipment 
recorded a mouse's fall on the plate below the rod during the 180 seconds total 
rotarod run window.  
 
Figure 2-5 Rotarod test profile 
The rotarod machine starts at 5 RPM and then ramps up to 40 RPM in 60 seconds. 
Then it stays at 40 RPM for rest of the rotarod test duration. 
 
A mouse's fall on the plate triggered the magnetic switches at the bottom of the 
plate and accurately detected and recorded the latency of fall (in seconds). 
Software Series 8 was provided with the equipment and it was used to record the 
latency of fall for the mice being tested. Each mouse performed three 
consecutive trials of the rotarod test, and all three latency of fall readings were 
averaged to yield a single test readout for a mouse at a time point. Next, the 
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averaged latency of fall readings per mouse in the three groups of mice 
(wildtype, heterozygous, and homozygous) were combined respectively at 3-
month time intervals - 3, 6, 9, and 12 months. The rotarod data were statistically 
compared between the wildtype and heterozygous H304R/+ and between 
wildtype and homozygous H304R/R mice at each time point using Student’s t-
test (two-tailed distribution, p<0.05) on the GraphPad Prism 6.0 software.  
2.3.4 Tail flick test 
Tail flick test was used to quantify the pain sensitivity response of H304R mice to 
thermal pain stimulus using Panlab tail flick meter (Harvard Apparatus # 
LE7106). A mouse is placed in the restrainer provided with the equipment and 
allowed to get habituated inside the restrainer for 2 minutes. Then the mouse tail 
is placed under a beam of thermal light and the meter records the time (in 
seconds) taken by the mouse to move its tail away from the source of thermal 
pain stimulus. Tail flick test data was collected and compared between 1, 3 and 
12 month wildtype, heterozygous H304R/+, and homozygous H304R/R male 
mice. 
 
Figure 2-6 Tail flick meter 
Sensitivity and response to thermal pain stimulus in mice is measured by tail flick meter. 
50 
 
2.4 Mouse dissections (sciatic nerve and dorsal root ganglia) 
Tissue from the peripheral nervous system of mice was dissected out by surgical 
procedures. Sciatic nerves and the dorsal root ganglia were collected from mice 
of 3 month and 12 months of age.  
2.4.1 Tissue harvesting and cryopreservation 
Mice were euthanized by administering CO2 and cervical dislocation. Sciatic 
nerve and lumbar dorsal root ganglia (DRG) samples were collected from both 
left and right side of the mice using Leica S8 AP0 Stereo Microscope. Collected 
tissue was fixed in 4% paraformaldehyde solution (EMS catalog#15710) for 30 
minutes at 4°C. Then the tissue was left in 30% Sucrose solution (weight/volume) 
overnight at 4°C. Next day, the tissue samples were embedded in labelled 
histology molds (Ted Pella, Inc. catalog # 27118) containing Tissue-Tek® O.C.T. 
Compound (Sakura Finetek USA Inc. catalog #25608-930). The tissue samples 
were rapidly frozen on dry ice and stored at -80°C in labelled freezer boxes.  
2.4.2 Cryosectioning and immunohistochemistry of tissue samples 
Frozen sciatic nerve or lumbar DRG was cryosectioned in 10µm size thin 
sections on Leica Cryostat (model# CM 1850) and collected on glass slides. The 
samples were then washed in 1X PBS (Gibco) thrice for 5 minutes each to clean 
away any O.C.T compound around the tissue. Waterproof boundaries were 
drawn around each tissue sample with ImmEdge Hydrophobic Barrier PAP Pen 
(Vector laboratories, catalog #H-4000). The tissue was permeabilized for 10 
minutes with permeabilization buffer (0.5% Triton-X100). Then block buffer (10% 
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normal goat serum and 0.1% Triton-X100 in PBS) was added for 60 minutes on 
the samples. Tissue samples were incubated with appropriate dilutions of 
primary antibodies (table 2-1) overnight at 4°C. Next day, the primary antibodies 
were washed with block buffer twice and then incubated with respective 
secondary antibodies for 2 hours at the room temperature. Unbound antibodies 
were washed with block buffer twice, followed by 1X PBS wash twice. The tissue 
samples were then mounted with ProLong™ Gold Antifade Mountant with DAPI 





Table 2-1 Antibodies used for tissue immunohistochemistry 
Primary antibody Labels Catalog number Dilution 
used 
Mouse monoclonal 




Abcam # 78078 1:200 
Rabbit polyclonal 
to Myelin Basic 
Protein (MBP) 
Myelinated axons Abcam # 40390 1:200 
Secondary 
antibody 







cells in the sciatic 
nerve’s 
perineurium 
Abcam # 15309 1:200 






Scientific # A11001 
1:200 











2.4.3 Microscopy and data analysis 
Images of sciatic nerve and dorsal root ganglia tissues were captured on the 
Leica M205 FA Fluorescence Microscope with Leica DFC3000G CCD camera. 
The microscope settings and configurations were kept uniform between all the 
samples to avoid variability (table 2-2).  
Table 2-2 Microscopic settings used for imaging 




Gain Intensity Magnification 
Green 515 nm 139 ms 2.5x 60% 80X 
Red 660 nm 139 ms 2.5x 40% 80X 
Blue 440 nm 2.6 sec 2.5x 100% 80X 
Transmittance none 139 ms 2.5x 45% 80X 
 
Collected sciatic nerve images were then analyzed on the ImageJ software 
(National Institutes of Health and the Laboratory for Optical and Computational 
Instrumentation) to calculate the cross-sectional area of the nerve. Threshold 
function was used to trace out the boundary of the nerve that was stained by the 
perineural marker GLUT-1 antibody. The area inside the traced-out threshold 
was measured using the ‘measure area’ function. The measured area (in mm2) 
was collected and compared between the wildtype, heterozygous H304R/+, and 
homozygous H304R/R mice.   
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2.5 Motility analysis studies in primary H304R neurons 
Primary neurons from the embryonic brains of H304R mouse model were 
dissected out and grown in vitro. Intracellular motility parameters were recorded 
in in vitro primary neurons to characterize the functions of dynein in H304R 
mouse model. 
2.5.1 Tissue harvesting of embryonic primary neurons 
Timed pregnancy breeding was set-up between the heterozygous male and 
female mice. The embryos were removed at embryonic day 16.5 from a 
euthanized pregnant female mouse. Brains were removed from each embryo and 
were dissected further to collect the cerebellar cortex and hippocampus from 
each lobe of the brain. Leica S8 AP0 Stereo Microscope was used for embryonic 
dissections. Cortices and hippocampi of wildtype, heterozygous (H304R/+), and 
homozygous (H304R/R) were then pooled together respectively after the 
genotype of the embryos was determined by the PCR based method. Cortical 
and hippocampal neurons were isolated respectively by enzymatic digestion 
technique with Papain (Worthington® Biochemical Corp# LS003118) and DNase 
(Worthington® Biochemical Corp # LK003172) in Hibernate® E minus 
Ca2+/Mg2+ media (BrainBits® # HECAMG500). Neurons were plated on 
0.3µg/ml poly-D-Lysine (Millipore Sigma) and 10µg/ml Laminin (ThermoFisher 
Scientific # 23017-015) coated 25mm Fisherbrand® glass coverslips (Catalog # 
12-545-102) in 6-well plates. The neurons were incubated at 37°C in warm 
Neurobasal™ media (ThermoFisher Scientific # 21103049) supplemented with 
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100X Antibiotic-Antimycotic (Gibco™ # 15240062), 50X B-27™ Supplement 
(Gibco™ # 17504044), and 100x GlutaMAX™ (Gibco™ # 35050061). The 
neurons were half fed by removing and replacing half of the media with fresh 
neuronal media every other day. 
2.5.2 Live neuronal imaging with Rab7-GFP labeled vesicles 
Cortical neurons of all 3 genotypes (wildtype, heterozygous (H304R/+), 
homozygous (H304R/R)) were nucleofected with Rab7-GFP plasmid using 
standard protocol on the Nucleofector™ 2b Device (Lonza # AAB-1001). The 
nucleofected neurons were then plated on the glass coverslips and incubated at 
37°C in warm NeurobasalTM media (ThermoFisher Scientific # 21103049). The 
nucleofected neurons were half fed with fresh media every other day.  
Live neuronal movies were captured on the Nikon® Eclipse Ti Inverted 
Microscope with Photometrics® Evolve EMCCD camera (#512) at D.I.V 10. The 
live cell movies were recorded using the Metamorph® Automation and Image 
Analysis Software (Molecular Devices). The movies were made at 100x 
magnification with 500 frames captured at the frame rate of 10 fps (frames per 
second) with the appropriate green fluorescence filter cube. The longest visible 
projection of the neuron was selected visually and was used for making neuronal 
movies to capture the motility events inside the neuronal projections. 
Motility analysis on movies of neurons containing Rab7-GFP labeled vesicles 
was done using the Kymograph function of the Metamorph® image analysis 
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software (Molecular Devices) and described in the next section. Motility 
parameters of Rab7-GFP labeled vesicles such as total number of movements, 
run length (µm), run velocity (µm/sec), and the direction of vesicular movement 
were calculated (figure 2-7). Motility data from different genotypes (wildtype, 
heterozygous (H304R/+), homozygous (H304R/R) were compared using one-
way ANOVA test on the GraphPad Prism®6 software. 
Kymograph analysis description  
The following Figure 2-7 is provided to illustrate the various features of 
kymographs. For this purpose, a hypothetical set of two vesicles is shown. 
Stationary vesicle is shown as a blue circle and a moving vesicle is shown as a 
red circle inside a cell (figure 2-7). The red vesicle is shown moving on a 
microtubule track shown with an orange line and the red vesicle is moving from 
point B to A. A kymograph line is drawn from the cell center to the periphery 
shown in the black line. The kymograph analysis of the black line is shown on the 
right in the form of a time (sec) vs distance (µm) graph. The blue stationary 
vesicle that does not move has a constant line as shown in blue indicating zero 
displacement on the time vs distance graph. In contrast, the red vesicle that 
moves shows the displacement as a slant line indicating a “run” on the time vs 
distance graph. The slope of the slant line gives the run velocity (µm/sec) and the 







Figure 2-7 Schematic diagram of motility analysis using kymographs 
Kymograph is a time vs distance graph generated to analyze the motility 
parameters on vesicles (blue circle = stationary vesicle, red circle = moving 





2.5.3 Live neuronal imaging with Synaptophysin-RFP labeled vesicles 
Cortical and hippocampal primary neurons were each infected with Bacmam 
Synaptophysin RFP (2µl/ml) (ThermoFisher Scientific # C10610) and incubated 
for 48 hours. Live neuronal movies were captured as mentioned in the sections 
above. Motility analysis of neurons containing Bacmam Synaptophysin RFP 
labeled vesicles was done using the Kymograph function of the Metamorph® 
Automation and Image Analysis Software (Molecular Devices). Motility 
parameters of Synaptophysin RFP positive vesicles such as total number of 
movements, run length (µm), run velocity (µm/sec), and the direction of vesicular 
movement were calculated. Motility data from different genotypes of mice 
(wildtype, heterozygous (H304R/+), homozygous (H304R/R)) were compared 
using one-way ANOVA test on GraphPad Prism®6 software.  
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CHAPTER 3: BEHAVIORAL PHENOTYPE CHARACTERIZATIONS 
OF H304R MICE 
 
3.1 Introduction 
Prior to our study, three other dynein heavy chain mutant mice were reported in 
the literature – legs at odd angle (Loa), Cramping (Cra), and Sprawling (Swl). 
Loa and Cra mice were generated using ENU-mediated mutagenesis (Hrabe de 
Angelis et al., 2000) and Swl was created using radiation induced mutagenesis 
(Duchen, 1974). All three mice displayed abnormal posture and hind limb 
clenching during the tail suspension. These transgenic mice were considered to 
be the paradigm mouse models of neurological dysfunction and were extensively 
studied. Some of the phenotypic studies on Loa, Cra, and Swl mice are outlined 
below.  
A multi-stage protocol called SHIRPA (Smith/Kline/Harwell/Imperial 
College/Royal Hospital/Phenotype Assessment) was used to quantitatively asses 
the phenotype of the Loa mouse in a longitudinal study (Rogers et al., 2001). The 
Loa/+ test results were compared with age and gender matched wildtype control 
mice in the behavioral and functional assessments done from 1 to 16 months of 
age. During the SHIRPA screening, the heterozygote Loa/+ and wildtype mice 
were assessed on tail suspension, grip strength, wire maneuver, and limb tone at 
1, 3 and 14-16 months age.  
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For grip strength testing, mice were gently pulled across a steel mesh grip and 
the grip strength exerted was recorded qualitatively with arbitrary scores: no 
effort= 0, slight semi-effective effort= 1, moderate effective effort= 2, active 
effort= 4, and unusual effective effort =5. For the wire maneuver test, mice were 
suspended on a horizontal wire by their fore limbs and the efforts to bring their 
hind limbs to the wire were scored as “falls immediately” to “active grip” with hind 
limbs. Lastly, in the hind limb tone assessment, mice were restrained in the 
supine position and their resistance to the pressure on the hind paws (plantar 
side) was recorded as “slight” or “moderate” or “heavy” resistance. Overall, the 
Loa/+ mice exhibited abnormal posture of hind limb clenching during tail 
suspension, significant reductions in hind limb (median score of 1= slight grip), 
reduced performance in the wire maneuver test (median score of 1= difficulty in 
grasping with hind limbs), and deficits in hind limb tone (median score of 1= slight 
resistance) as compared to the wildtype control mice. 
For another stage of SHIRPA protocol, Loa/+ mice performed the rotarod test 
and spontaneous locomotor activity test. For the rotarod test, the test mouse was 
placed on a rotating rotarod and time when a mouse would fall off from a rotarod 
was recorded. In locomotor activity test, a mouse was placed in a clear Perspex 
activity cage fitted with infra-red signals, and the infra-red beam breaks induced 
by the mouse locomotion was detected and recorded over a 30 minutes test 
window. The Loa/+ mice had a significant reduction in its rotarod performance at 
1, 3 and 16 months’ time points as they were unable to stay on the rotarod as 
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long as the control wildtype mice. During locomotion test, the Loa/+ mice 
interestingly showed more locomotor activity than the wildtype control mice. In 
conclusion, the SHIRPA protocol of behavioral assessments provides a 
comprehensive methodology for documenting progressive neurological 
dysfunction in mouse models (Rogers et al., 2001).  
The other two DHC mutant mice – Cra and Swl were also characterized using 
SHIRPA protocol for their neurological functions. Just like Loa/+ mice, both Cra/+ 
and Swl/+ mice displayed hind limb clenching during tail suspension, gait 
abnormalities, no reductions in front grip strength, and significantly reduced grip 
strength in hind limbs (Banks and Fisher, 2008; Chen et al., 2007). The 
homozygous Loa/Loa, Cra/Cra, and Swl/Swl mice were either embryonically 
lethal or did not survive 24 hours post birth due to their inability to feed (Chen et 
al., 2007; Hafezparast et al., 2003). Overall, the DHC mutant Loa, Cra, and Swl 
mice models provided some interesting evidences in the role of dynein in 
neurological dysfunction. 
3.2 Rationale 
The mutagenesis generated Loa, Cra and Swl mice have provided many key 
insights in understanding the dynein function, however, the mutations in Loa 
(F8580Y), Cra (Y1055C), and Swl ([GIVT]1040[A]) are not linked to any 
neurodegenerative disease alleles in humans. It is hard to correlate their key 
findings in understanding the dynein function in the context of neurodegenerative 
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diseases in humans. Discovery of the first dynein mutation (H306R) in human 
neuropathy (CMT2O) was an opportunity to study dynein function. Hence, we 
generated the novel H304R mouse model as a tool to understand the dynein 
function and mechanism in human neurodegenerative diseases.  
The H304R mouse model has a mutation in its dynein heavy chain that is 
reported to lead to human neuropathies such as Charcot-Marie-Tooth Type 2O 
disease (CMT2O) and Spinal Muscular Atrophy with Lower Extremity Dominant 
(SMA-LED). Both CMT2O and SMA-LED patients exhibit similar clinical 
symptoms such as they display lower limb weaknesses, muscle wasting, skeletal 
and joint deformities of foot, joint contractures, and problems in walking. CMT2O 
patients also show a loss of sensation symptoms in addition to their motor 
defects. The disease linked Histidine to Arginine substitution mutation is at 
position 306 in the human dynein heavy chain, and the corresponding mutation is 
at position 304 in mouse dynein heavy chain (Figure 3-1). 
 
Figure 3-1 Comparison of dynein heavy chain peptide 
CMT2O disease linked mutation is a missense substitution of Histidine (H) to Arginine 
(R) at position 306 in human dynein heavy chain peptide. The corresponding mutation is 
at position 304 in mouse dynein heavy chain peptide. 
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We generated the novel H304R mouse model using knock-in gene targeting 
technique (Sabblah et al., 2018). It is critical to remember that because a mouse 
has a disease linked mutation, it does not mean that it would be a relevant model 
to study that disease. A mouse model has to recapitulate the clinical 
manifestations of the disease to be considered as a relevant model for studying 
that disease. Therefore, a key question for the H304R mouse model was if the 
H304R mice would develop and display the symptoms associated with CMT2O.  
To answer this question, we performed extensive studies to investigate and 
characterize the behavioral phenotype of the H304R mouse model. Several 
phenotypic assessments and motor-skills tests were performed at multiple time 
points to investigate if the H304R mouse model recapitulated the corresponding 
phenotype associated with CMT2O. First, we started with breeding and growing 
the heterozygous H304R/+ colony for preliminary behavioral assessments. The 
initial assessments such as tail suspension reflex, grip strength, and rotarod test 
were performed with the heterozygous H304R/+ male and female mice and the 
data was compared with the wildtype mice. The preliminary findings between the 
heterozygous H304R/+ and wildtype mice were published first (Sabblah et al., 
2018).  
After seeing a promising phenotype with the heterozygous H304R/+ mice, we 
decided to start another behavioral skills study with the homozygous H304R/R 
mice. The homozygous H304R/R mice were then bred and grown into a colony 
of mice. We compared the tail suspension reflex, grip strength, and rotarod data 
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between the homozygous H304R/R mice and the wildtype control mice at 
multiple ages (manuscript in submission). 
3.3 Results 
3.3.1 H304R mice had normal life span 
The founder H304R knock-in mice were bred to yield both male and female 
heterozygous H304R/+ mice. The heterozygous H304R/+ pups had a normal 
birth and normal lifespan of 2 years (Sabblah et al., 2018). The heterozygous 
H304R/+ mice did not appear to have any significant bodyweight differences and 
were able to move around the cage just like their littermate wildtype control 
animals. 
The homozygous H304R/R pups were able to survive after birth unlike the other 
dynein heavy chain homozygous mutant pups (Loa/Loa, Cra/Cra, Swl/Swl) and 
had a normal lifespan (Chen et al., 2007; Hafezparast et al., 2003). The 
homozygous H304R/R mice appeared to have gait defects such as a high 
steppage gait in hind limbs (figure 3-2). Also, they were not as inclined to move in 
the cage as compared to their littermate wildtype control and heterozygous 
H304R/+ mice. They did not have any significant bodyweight differences 




Figure 3-2 Gait phenotype of H304R mouse model 
Homozygous H304R/R mice showed gait defects such as high steppage gait in hind 
limbs (black arrow). 
 
 
3.3.2 H304R mice showed atypical tail suspension phenotype 
Tail suspension tests were performed to assess the phenotype of H304R mouse 
model. Mice tend to splay their hind limbs away from their body when lifted by the 
tails as their typical tail suspension reflex. However, in some cases, mice would 
clench their hind limbs together and hold them close to their body as part of their 




Figure 3-3 Tail suspension phenotype of H304R mouse model 
Typical tails suspension reflex consists of splaying of hind limbs away from the body, 
whereas, atypical tail suspension involves clenching of hind limbs together closer to the 
body. 
 
The tail suspension reflex test was performed on the H304R colony at multiple 
ages and the mouse’s phenotype was scored as typical or atypical reflex. The tail 
suspension reflex was then statistically compared between the 3 genotypes 
using the Chi-square test (p<0.05). We observed that about 20-30% of male and 
female heterozygous H304R/+ mice started to display the atypical tail suspension 
phenotype at later ages (9 and 12 months) as compared to the wildtype control 
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mice (Figure 3-4). A majority (60-80%) of male and female homozygous 
H304R/R mice significantly displayed the atypical tail suspension reflex 
compared to the wildtype control and heterozygous H304R/+ mice right from an 
early age. The tail suspension data is summarized in Table 3-1. 
 
 
Figure 3-4 Atypical tail suspension response of H304R mouse model 
Male and female heterozygous H304R/+ mice (gray bars) showed atypical tail 
suspension reflex at later time points as compared to the wildtype mice (black bars) 
(Chi-square test p<0.05). Whereas, both male and female homozygous H304R/R mice 
(white bars) showed atypical tail suspension reflex at all the time points (Chi-square test 
p<0.05). Note- * is the statistical significance as compared to the wildtype only and # is 
the statistical significance as compared to the wildtype and H304R/+.  


























Percentage of mice showing 
atypical tail suspension 
reflex 
Number of animals (n) p-value  
(Chi-square 
test) 
Wild-type H304R/+  H304R/R Wild-
type 














7.5% 2.0% 61.7% 34 25 26 0.0745 <0.0001 
6 
months 
5.8% 11.2% 76.6% 46 34 20 0.0642 <0.0001 
9 
months 
9.6% 21.6% 74.7% 29 27 20 0.0120 <0.0001 
12 
months 










10.0% 15.4% 66.3% 9 8 27 0.5434 <0.0001 
6 
months 
8.0% 12.5% 62.6% 35 21 20 0.2771 <0.0001 
9 
months 
11.3% 18.6% 70.9% 54 37 19 0.0314 <0.0001 
12 
months 
11.3% 18.5% 70.7% 56 44 19 0.0350 <0.0001 
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3.3.3 Heterozygous H304R/+ mice show mild defects in their motor phenotype  
Initial behavioral assessments were done with the male and female heterozygous 
H304R/+ mice and the data was statistically compared with age and gender 
matched wildtype control mice. The behavioral test results are as follows: 
Heterozygous H304R/+ mice show reductions in grip strength 
Standard grip strength assay was performed to assess the muscular strength in 
all limbs and front limbs of heterozygous H304R/+ mice. The male heterozygous 
H304R/+ mice showed a statistically significant reduction of about 10% in all 
limbs grip strength at all ages as compared to the wildtype control mice 
(Student’s t-test, p<0.05) (Figure 3-5). Female heterozygous H304R/+ mice 
showed a statistically significant reduction of about 5% in all limbs grip strength 
at only 6 and 9 month ages as compared to the wildtype control animals 
(Student’s t-test, p<0.05).  
Male heterozygous H304R/+ mice showed a statistically significant reduction of 
about 7% in its front grip strength at later ages of 9 and 12 months as compared 
to the wildtype mice (Student’s t-test, p<0.05). The female heterozygous 
H304R/+ mice did not have any reductions in their front grip strength as 
compared to the wildtype mice at any age. The grip strength data for male 






Figure 3-5 Grip strength phenotype of heterozygous H304R/+ mice 
Both male and female heterozygous H304R/+ mice showed significant reductions in all 
limbs grip strength as compared to the wildtype mice (A & B). Only male heterozygous 
H304R/+ mice showed significant reductions in front limbs grip strength at later time 
points (C). The female heterozygous H304R/+ mice did not show any reductions in front 


















Wild-type H304R/+  Wild-
type 








212.5 ± 23.2 190.4 ± 26.8 50 43 0.0001 
6 
months 
225.1 ± 30.8 201.0 ± 29.9 62 58 0.0001 
9 
months 
230.6 ± 37.9 206.8 ± 33.4 41 42 0.0033 
12 
months 






99.2 ± 12.9 95.6 ± 17.4 50 43 0.2654 
6 
months 
88.8 ± 14.3 83.8 ± 15.0 62 58 0.0667 
9 
months 
89.8 ± 12.9 82.1 ± 11.1 41 42 0.0045 
12 
months 



















Wild-type H304R/+  Wild-
type 








175.5 ± 24.0 171.9 ± 22.0 51 35 0.4820 
6 
months 
192.9 ± 15.9 185.7 ± 16.9 56 41 0.0324 
9 
months 
209.8 ± 18.8 199.8 ± 16.5 55 41 0.0068 
12 
months 






91.0 ± 12.5 89.1 ± 12.2 51 35 0.4801 
6 
months 
81.5 ± 9.8 81.8 ± 11.0 56 41 0.8959 
9 
months 
81.3 ± 11.8 79.8 ± 11.1 55 41 0.5148 
12 
months 











Heterozygous H304R/+ mice show deficits in the rotarod performance 
Rotarod test was performed to assess the motor coordination phenotype of 
H304R/+ mice. Mice were placed inside the rotarod equipment and their falling 
off from the rotarod before the completion of the rotarod cycle was measured as 
latency to fall (in seconds). The male heterozygous H304R/+ mice were falling 
from the moving rotarod quicker than the wildtype mice (Table 3-5). They showed 
significant reductions in their latency to fall (by about 25%) as compared to the 
wildtype control animals at 3, 6 and 9 months of age (Student’s t-test, p value 
<0.05) (Figure 3-6). Female heterozygous H304R/+ mice also showed a similar 
trend (Table 3-5), but had a significant reduction of 20% in their latency to fall 
only at an early age of 3 months as compared to the wildtype mice (Student’s t-
test, p value <0.05). 
 
Figure 3-6 Rotarod performance test of the H304R/+ mice 
Male and female heterozygous H304R/+ mice showed significant defects in their rotarod 
performance as compared to the wildtype at some time points (*Student’s t-test, p<0.05).  
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Wild-type H304R/+  Wild-
type 




3 months 78.8 ± 40.9 55.2 ± 30.4 51 43 0.0019 
6 months 95.5 ± 49.1 73.0 ± 42.4 48 41 0.0223 
9 months 101.9 ± 52.9 74.6 ± 44.8 28 33 0.0359 















Wild-type H304R/+  Wild-
type 




3 months 103.6 ± 47.6 82.7 ± 34.3 51 35 0.0205 
6 months 113.7 ± 54.9 104.9 ± 45.2 51 35 0.4210 
9 months 106.8 ± 61.4 105.9 ± 54.0 51 35 0.9386 




3.3.4 Homozygous H304R/+ mice show severe defects in their motor phenotype  
After seeing the altered phenotype of motor skills in the heterozygous H304R/+ 
mice, we decided to perform behavioral assessments of the male and female 
homozygous H304R/R mice. The data was statistically compared with age and 
gender matched with the wildtype control mice. The behavioral test results are as 
follows: 
 
Homozygous H304R/R mice show reductions in grip strength 
Standard grip strength assay was performed to assess the muscular strength in 
all limbs and front limbs of heterozygous H304R/R mice. Male homozygous 
H304R/R mice showed statistically significant reductions of about 30% in all 
limbs grip strength as compared to the wildtype animals at all ages (Student’s t-
test, p value <0.05) (Figure 3-7). Female homozygous H304R/R mice also 
showed statistically significant reductions of about 20% in all limbs grip strength 
as compared to the wildtype animals at all ages tested (Student’s t-test, p value 
<0.05). Both male and female homozygous H304R/R mice did not show any 
reductions in their front grip strength as compared to the wildtype mice at all 
ages. Grip strength data for male homozygous H304R/R (Table 3-6) and female 







Figure 3-7 Grip strength phenotype of heterozygous H304R/R mice 
Both male and female homozygous H304R/R mice showed significant reductions in all 
limbs grip strength (A & B) as compared to the wildtype controls. No grip strength 
reductions were observed in the front limbs of both male and female homozygous 

























212.5 ± 23.2 162.0 ± 46.3 50 26 <0.0001 
6 
months 
225.1 ± 30.8 162.9 ± 31.4 62 20 <0.0001 
9 
months 
230.6 ± 37.9 162.2 ± 38.6 41 20 <0.0001 
12 
months 





99.2 ± 12.9 96.0 ± 23.6 50 26 0.9995 
6 
months 
88.8 ± 14.3 84.6 ± 21.7 62 20 0.9970 
9 
months 
89.8 ± 12.9 85.8 ± 18.8 41 20 0.9987 
12 
months 
































175.5 ± 24.0 154.5 ± 23.0 51 27 0.0004 
6 
months 
192.9 ± 15.9 164.9 ± 28.5 56 20 0.0004 
9 
months 
209.8 ± 18.8 161.0 ± 29.5 55 19 <0.0001 
12 
months 






91.0 ± 12.5 91.5 ± 15.5 51 27 >0.9999 
6 
months 
81.5 ± 9.8 81.7 ± 17.0 56 20 >0.9999 
9 
months 
81.3 ± 11.8 81.6 ± 17.9 55 19 >0.9999 
12 
months 





Homozygous H304R/R mice show deficits in the rotarod performance 
Homozygous H304R/R mice were unable to keep up with the rotating rotarod 
and were falling off the rod a lot quicker than the wildtype mice. Male 
homozygous H304R/R mice showed statistically significant reductions in their 
latency to fall as compared to the wildtype at all ages (Student’s t-test, p value 
<0.05) (Figure 3-8). Similarly, female homozygous H304R/R mice also showed 
statistically significant reductions in their rotarod performance as compared to the 
wildtype mice at all ages tested (Student’s t-test, p value<0.05). Both male (Table 
3-8) and female (Table 3-9) homozygous H304R/R mice showed about 65% 
reduction in their latency to fall as compared to the wildtype mice. 
 
Figure 3-8 Rotarod performance test of the H304R/R mice 
Both male and female homozygous H304R/R mice showed significant defects in their 





















3 months 78.8 ± 40.9 25.0 ± 9.6 51 26 <0.0001 
6 months 95.5 ± 49.1 22.4 ± 9.7 48 20 <0.0001 
9 months 101.9 ± 52.9 17.8 ± 9.6 28 20 <0.0001 
12 months 100.7 ± 48.6 18.8 ± 9.7 20 18 <0.0001 
 
 

















3 months 103.6 ± 47.6 28.1 ±  9.1 51 27 <0.0001 
6 months 113.7 ± 54.9 30.8 ±  18.7 51 20 <0.0001 
9 months 106.8 ± 61.4 23.9 ±  12.0 51 19 <0.0001 





We generated a novel H304R mouse model for Charcot-Marie-Tooth type 2O 
(CMT2O) with a disease mutation in its dynein heavy chain. We performed 
several phenotypic and behavioral assessments on male and female 
heterozygous H304R/+ and homozygous H304R/R mice. The heterozygous 
H304R/+ had a normal lifespan and survived until 2 years (end point of the 
study). Similarly, the homozygous H304R/R mice had a normal lifespan unlike 
the other dynein heavy chain mutant mice (Loa/Loa, Cra/Cra, and Swl/Swl) that 
were embryonic or post-natal lethal (Chen et al. (2007); (Hrabe de Angelis et al., 
2000). 
Male and female heterozygous H304R/+ mice showed an atypical tail suspension 
reflex of hind limb clenching at later ages (9 and 12 months). The atypical tail 
suspension phenotype could be indicative of motor dysfunction in lower 
extremities (or hind limbs) of the mice. Male and female heterozygous H304R/+ 
mice showed significant reductions of 5-10% in their hind limbs grip strength. 
Only male heterozygous H304R/+ mice showed significant reductions in the front 
limbs grip strength at later ages (9 and 12 months). Additionally, male 
heterozygous H304R/+ mice also showed significant ~25% reduction in the 
rotarod performance almost at all the time points. Female heterozygous H304R/+ 
mice showed a significant ~20% reduction in the rotarod performance test at an 
early age only (3 months). 
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Male and female homozygous H304R/R mice appeared to have defects in their 
gaits and were inclined to move less inside the cage as compared to their 
littermates. The majority of homozygous H304R/R significantly showed atypical 
tail suspension reflex right from an early age 3 months to all the way up to 12 
months. Male and female homozygous H304R/R mice also showed significant 
20-30% reductions in all limbs grip strength as compared to the wildtype mice, 
but not in front limbs grip strength. Both male and female homozygous H304R/R 
mice also performed poorly on the rotarod performance test with ~65% reduction 
in latency to fall because they were unable to stay longer on the moving rod than 
the wildtype control mice. 
 
So far, our initial investigation and characterization of the novel H304R mice with 
CMT2O mutation in DHC offered the following insights: 
 The H304R mouse model is a novel mouse model with a mutation in the 
dynein heavy chain that is known to cause neuropathies in humans 
(CMT2O and SMA-LED) (Tsurusaki et al. (2012); (Weedon et al., 2011). 
 The H304R mouse model was able to recapitulate and express the 
symptoms of human neuropathies (CMT2O and SMA-LED) such as 
muscle weaknesses, and motor coordination defects.  
 The heterozygous H304R/+ mutation expressed and recapitulated the 
heterogeneity of motor phenotype in mice, similar to the heterogeneity of 
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clinical symptoms seen in humans with the autosomal dominant CMT2O 
mutation. 
 Quantitatively, the heterozygous H304R/+ mice displayed a milder 
reduction in its motor skills phenotype, whereas, the homozygous 
H304R/R mice displayed a severe reduction in its motor skills phenotype.  
 The male heterozygous H304R/+ mice appeared to be affected more 
significantly by the mutant dynein function than the female heterozygous 
H304R/+ mice.  
 The male heterozygous H304R/+ mice had a variable onset of the motor 
phenotype, sometimes at an early age (reductions in all limbs grip strength 
and rotarod tests) and sometimes at a later age (atypical tail suspension 
and reduced front limbs grip strength). 
 Both male and female homozygous H304R/R mice appeared to be 
affected equally by the mutant dynein function. 
 The homozygous H304R/R mice consistently had an early onset of motor 
phenotype that was severely deficient right from the start. In addition, the 
homozygous H304R/R mutation phenotype was also static and non-
progressive in nature, i.e. it was not worsening drastically as the mice 
aged. 
 A dynein molecule contains a dimer of two DHC monomeric peptides 
linked together. A unique advantage of the homozygous H304R/R 
mutation is that the homozygous mice will have a uniform composition of 
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dynein molecules with DHC dimers containing both mutant monomers. In 
contrast, the heterozygous H304R/+ mutation leads to a mixed pool of 
dynein in heterozygous mice, i.e. a quarter population of DHC dimers will 
have both wildtype monomers, a quarter of DHC with both mutant 
monomers, and half of the DHC dimers with one wildtype and one mutant 
monomer.   
 
In conclusion, the H304R mouse model appears to serve as a useful tool to 
understand the role of dynein in neurodegenerative diseases. Future biochemical 
studies with H304R mice can unveil the molecular mechanism of the mutant 
dynein function in neurons.  
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CHAPTER 4: SENSORY PHENOTYPE CHARACTERIZATIONS OF 
H304R MICE 
4.1 Introduction 
Many CMT patients show the symptoms of sensory neuropathy along with motor 
neuropathy. Common sensory deficits reported in CMT patients include loss of 
sensation in distal limbs, paresthesia (tingling sensation), reduced 
proprioception, and some patients also displayed reduction in their fine touch and 
vibration sense (Weedon et al., 2011). Due to loss of sensation in their lower 
limbs, some patients lose sensitivity to pain due to any foot wounding. 
Consequently, that further leads to complications of foot ulcerations and usually a 
follow up surgery is needed to remove the damaged foot/toes. It is worth noting 
that previously published dynein heavy chain mutant mice (Loa, Cra and Swl) 
reported sensory deficits in their phenotype (Chen et al., 2007; Dupuis et al., 
2009) as outlined below. 
4.1.1 Sensory deficits in previously published mutant dynein mice models  
The sciatic nerve is the largest nerve in the body, and it innervates the lower limb 
muscles of mice. The outer layer of dense irregular connective tissue around a 
sciatic nerve is called epineurium (Figure 4-1). The sciatic nerve is made up of 
fascicles i.e. the several bundles of neuronal axons that are enclosed together. 
The outer layer of a fascicle is lined with perineural glial cells and is called the 
perineurium. The extracellular matrix space between neuronal axons inside a 




Figure 4-1 Sciatic nerve cross section 
The sciatic nerve is covered with a layer of connective tissue called epineurium and 
contains several nerve bundles called fascicles. The fascicles are lined with glial cells 
that make up a layer called perineurium. The extracellular space around the bundles of 
axons inside the fascicles is called endoneurium. 
 
Deficits in the sciatic nerve anatomy have been linked to sensory dysfunction in a 
previously reported dynein heavy chain mutant mouse (Chen et al., 2007). Both 
heterozygote Loa/+ and heterozygote Swl/+ mice reportedly had thinner sciatic 
nerves as compared to wildtype animals. Both ventral root and dorsal root 
contribute their spinal nerves (neuronal axons) to make up the sciatic nerve. It 
was observed and determined that the dorsal root size was smaller in both 
heterozygote Loa/+ and Swl/+ mice as compared to wildtype controls, whereas 
the ventral root size was unchanged. The Cra/+ mice also showed thinner dorsal 
roots and loss of large caliber axons (Dupuis et al., 2009) 
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A dorsal root ganglion is a cluster of neuronal cell bodies or somas of pseudo-
unipolar sensory neurons. The dorsal root ganglia (DRG) receive input signals 
from sensory neurons innervating target tissue such skin, muscles, and organs. 
Input nerve signals travel along the sensory neuron axons in ‘afferent direction’ 
i.e. from target tissue to dorsal root ganglia and further passed onto the spinal 
column for signal processing. Additionally, the dorsal root ganglion is composed 
of different neuronal subpopulation involved in sensory stimulus reception. For 
example, nociceptive neuronal subpopulation inside a dorsal root ganglion is 
responsible for sensing pain stimulus from the target tissue such as skin. Another 
example inside a dorsal root ganglion is the proprioceptive neuronal 
subpopulation that is involved in sensing the muscle stretch and orientation.  
In the study mentioned above, the DRG in heterozygote Loa/+ and heterozygote 
Swl/+ mice were also examined, and they revealed interesting insights into the 
DRG neuronal subpopulation composition (Chen et al., 2007). It was determined 
that the total number of neurons were significantly reduced in dorsal root ganglia 
from lumbar (L4) spinal region of heterozygote Loa/+ and heterozygote Swl/+ 
mice. Specifically, it was determined that proprioceptive neuronal subpopulations 
were reduced by 69% in the dorsal root ganglia (L4) of newly born heterozygote 
Swl/+ animals. Proprioceptive neuronal subpopulation count was not studied in 
heterozygote Loa/+ mice. In conclusion, the sensory studies on heterozygote 
Loa/+ and Swl/+ mice laid out the basis for investigating the sensory phenotype 




We focused on the motor behavior skills characterization of the novel H304R 
mouse in our initial studies and observed deficits in the tail suspension, grip 
strength and the motor coordination phenotype of the mice. Here I start 
investigating the sensory phenotypes of H304R mice to understand and compare 
those to the sensory phenotypes of previously published dynein heavy chain 
mutant mice (Loa/+ and Swl/+).  
First, I started with assessing the sensory behavior phenotype by exposing 
wildtype, heterozygous H304R/+, and homozygous H304R/R mice (both male 
and female) to the tail flick sensitivity test and recorded their response to pain 
stimulus at early (1 month and 3 months) and a later (12 months) time point. 
Based on the tail flick data, I selected the male H304R mice cohort at 3 and 12 
months’ time points for further sensory tissue investigation. I examined the gross 
anatomy of sciatic nerve in the wildtype, heterozygous H304R/+, and 
homozygous H304R/R male mice at 3 and 12 months of age and compared its 
thickness in all three genotypes. I dived deeper into quantitative analysis of 
sciatic nerve thickness by comparing the total fascicular area in the sciatic nerve 
from the male H304R mice of all three genotypes. Because the dorsal root 
ganglia (DRG) contribute its axons to the sciatic nerve, I refined and optimized 
conditions to study the DRG composition to further understand the sciatic nerve 




4.3.1 Altered latency to respond to pain stimulus in H304R mice 
The tail flick test was used to measure the sensitivity of H304R mice to thermal 
pain stimulus. A test mouse was restrained safely in a restrainer and its tail was 
briefly exposed to a thermal light beam as a source of pain stimulus at a 
moderate intensity setting (50 out of 99 on the setting scale). The tail flick meter 
recorded the time (in seconds) that a mouse would take to remove its tail out of 
the thermal light beam path (pain stimulus). Both male and female cohorts of 
H304R mice were tested on the tail flick test at multiple time points and their data 
was compared respectively between the three genotypes. 
 
Figure 4-2 Tail flick pain sensitivity test of H304R male mice 
Male homozygous H304R/R mice displayed a significantly quicker response to the pain 
stimulus at 3 months and 12 months of age as compared to their respective wildtype 
control male mice (One-way ANOVA, p<0.05). Only 3 month female homozygous 
H304R/R mice displayed a significant quicker response to the pain stimulus as 
compared to the wildtype control female mice (One-way ANOVA, p<0.05). 12 month old 
female homozygous H304R/R data is not presented due to the unavailability of mice. 



































































































































































































Interestingly, both heterozygous H304R/+ and homozygous H304R/R male mice 
took less time to respond to the pain stimulus than the wildtype control mice 
(Figure 4-2) at multiple time points. However, the quick response time was 
statistically significant only in the homozygous H304R/R male mice at 3 months 
and 12 months of age (One-way ANOVA, p<0.05) as compared to the wildtype 
mice. There was no significant difference between the pain response time of 
heterozygous H304R/+ and homozygous H304R/R male mice at any time points 
tested (Table 4-1).  
Female heterozygous H304R/+ and homozygous H304R/R mice did not show 
any significant differences in their tail flick response times as compared to the 
wildtype control female mice at 1 month of age. However, at 3 months of age, 
both heterozygous H304R/+ and homozygous H304R/R female mice took lesser 
time to respond to the pain stimulus. But only homozygous H304R/R female mice 
had a statistically significantly quicker response time as compared to the wildtype 
control mice (One-way ANOVA, p<0.05). The tail flick data for 12 month old 
female homozygous H304R/R mice is not presented due to a lack of the mouse 
availability. There was no significant difference between the pain response time 






Table 4-1 Tail flick data 
Average time of response (sec), number of animals (n), and the one-way ANOVA test p-values (with Tukey’s multiple 







Average time of response 
to the pain stimulus 
(seconds) 





















 1 month 8.13 7.28 4.46 3 13 2 0.9051 0.4203 0.4743 
3 months 8.64 6.40 5.21 7 18 6 0.0843 0.0284 0.5117 








 1 month 7.60 7.77 7.86 5 9 4 0.9876 0.9796 0.9968 
3 months 8.43 7.04 4.59 9 12 4 0.3108 0.0163 0.1335 
12 months 10.43 7.83 N/A 4 4 N/A N/A N/A N/A 
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4.3.2 Sciatic nerve appeared thinner in H304R mice 
The sciatic nerve is the largest nerve in the body and it innervates the lower 
limbs of mice. The sciatic nerve arises from spinal nerves L3, L4, and L5 from the 
lumbar spinal column in mice. Dissections were performed on euthanized 
wildtype, heterozygous H304R/+, and homozygous H304R/R male mice to 
expose & collect both left and right sciatic nerves. Then, the tissue was frozen, 
sectioned and stained with immunohistochemistry-based methods to compare 
the sciatic nerve thickness between the three genotypes.  
Sciatic nerve dissections were done on two litters each of 3 months and 12 
month old wildtype, heterozygous H304R/+, and homozygous H304R/R male 
mice. Visually, it appeared that both the left and right sciatic nerves were thinner 
in the male homozygous H304R/R mice as compared to the wildtype and 
heterozygous H304R/+ littermate control (Figure 4-3). Heterozygous H304R/+ 
mice appeared to have sciatic nerves of similar or slightly reduced thickness as 
compared to the wildtype littermate control animals. These visual observations of 
sciatic nerve were then further validated by quantitatively measuring the nerve 
thickness and axonal counts using immunohistochemistry-based staining 







Figure 4-3 Comparison of sciatic nerve thickness of H304R male mice 
The sciatic nerve appeared to be thinner in 3-month homozygous H304R/R male mice 
as compared to the wildtype and heterozygous H304R/+ littermates. 
 
4.3.3 Reduced total sciatic nerve fascicular area in H304R mice 
After seeing apparent differences in sciatic nerve thickness of H304R mice, I 
wanted to quantify this observed difference by measuring the total fascicular 
area. The sciatic nerve is made up of fascicles or bundle of neuronal axons 
enclosed within the perineurium layer. Fascicular area was calculated by 
measuring the area enclosed inside perineurium layer of fascicles that was 
stained by a perineural marker - glucose transporter GLUT-1 antibody (details in 
Chapter 2: Materials and methods). Total area of all the fascicles were added 
together and compared between the 3-month (Figure 4-4) and 12-month (Figure 









Figure 4-4 Sciatic nerve cross sections of 3-month H304R male mice 
Sciatic nerve cross sections were stained with perineural glial maker – GLUT 1 (shown here in red) to label individual 
fascicles. Total fascicular area was calculated for all fascicles and compared between the genotypes. Homozygous H304R/R 
mice showed a significant reduction in the total fascicular area as compared to wildtype littermate control. No significance 











Figure 4-5 Sciatic nerve cross sections of 12-month H304R male mice 
Sciatic nerve cross sections were stained with perineural glial maker – GLUT 1 (shown here in red) to label individual 
fascicles. Total fascicular area was calculated for all fascicles and compared between the genotypes. Homozygous H304R/R 
mice showed a significant reduction in the total fascicular area as compared to wildtype littermate control. No significance 
differences were observed between heterozygous H304/R+ and wildtype mice. 





By visual observation, the sciatic nerve appeared thinner in homozygous 
H304R/R male mice as compared to the wildtype littermate control animal at both 
3 months and 12 months of age. This result was quantitatively confirmed by 
observing a significant overall reduction of about 40% in total fascicular area of 
homozygous H304R/R mice as compared to the wildtype control (One-way 
ANOVA, Tukey’s multiple comparisons test, p<0.05) at 3 months and 12 months 
age (Figure 4-6). Heterozygous H304R/+ mice also showed about 16% reduction 
in the total fascicular area as compared to the wildtype littermate control animal 
at 3 months and 12 months age, but this difference was not statistically 
significant. Total fascicular area differences between homozygous H304R/R and 
heterozygous H304R/+ male mice were not significant (Table 4-2).  
 
Figure 4-6 Total fascicular area of sciatic nerve in H304R male mice 
Homozygous H304R/R male mice had a statistically significant reduction of ~40% in its 
total fascicular area as compared to the wildtype control mice (1-way ANOVA, Tukey’s 






































0.20 mm2 0.16 mm2 0.12 mm2 
3-month 
littermate #2 
0.16 mm2 0.14 mm2 0.09 mm2 
Average 3 -
month area 
0.18 mm2 0.15 mm2 0.11 mm2 









0.19 mm2 0.20 mm2 0.12 mm2 
12-month 
littermate #2 
0.17 mm2 0.10 mm2 0.10 mm2 
Average 12 -
month area 




4.3.4 Axonal counts in the sciatic nerve cross section 
After seeing a reduction in the total fascicular area of the sciatic nerve, it was 
apparent that the axon numbers inside the fascicles were needed to be counted 
to reveal any alterations that may have led to this reduction. Alterations in total 
fascicular area could be a result of reduced number of the axons or a reduction in 
the myelination that could ultimately lead to the thinner nerves of heterozygous 
H304R/+ and homozygous H304R/R mice.  
The largest βIII tubulin stained fascicle from each genotype of 3-month littermate 
male mice was selected (Figure 4-7). The axons were counted and recorded in 
two categories based on their appearances – single axons and bundled axons. A 
small and uniform green dot was counted as a single axon, while the larger 
shaped green dot was counted as a bundle of multiple axons inside the fascicle. 
Then the percentage of bundled axon over total axons and the percentage of 
single axons over total axons were calculated and compared separately for all 
three genotypes (Table 4-3). The preliminary results revealed a reduction in the 
number of axons in both the heterozygous H304R/+ and homozygous H304R/R 
mice (Figure 4-8). However, the percentage distribution of the total axons into 














Figure 4-7 The largest fascicle inside the sciatic nerve of each genotype 
The cross-sectional area of the largest fascicle inside each sciatic nerve was stained with the βIII tubulin antibody. Each 
green dot was counted as a single axon and a bunch of green dots were counted as a bundle of multiple axons. 
 
 
Wildtype H304R/+ H304R/R 
100 
 
Table 4-3 Axon counts inside the largest fascicle 
3 months Wildtype H304R/+ H304R/R 
Bundled axons 629 461 362 
Single axons 579 397 282 
Total axons 1208 858 644 
% of bundled axons 52.07% 53.73% 56.21% 




Figure 4-8 Total count of axons inside a fascicle  
The total number of axons was counted in the cross-sectional area of the largest fascicle 





Figure 4-9 The percentage distribution of bundled axons vs single axons 
The distribution of the total axons in the categories – bundled axons and single axons 












4.3.5 Identifying subpopulations of neurons in the adult DRG 
After observing a significant reduction in sciatic nerve thickness and axonal count 
in H304R mice, I wanted to determine if there was a corresponding alteration in 
the dorsal root ganglia (DRG) composition. The DRG contribute its neuronal 
axons to make up the sciatic nerves. The DRG contain a mixed subpopulation of 
neurons such as nociceptive neurons (to sense pain) and proprioceptive neurons 
(to sense muscle stretch and orientation). DRGs collected from the lumbar (L4) 
region of wildtype, heterozygous H304R/+, and homozygous H304R/R male mice 
were sectioned serially every 10µm and stained with anti-βIII tubulin antibody to 




Figure 4-10 Serial sections of dorsal root ganglia of H304R mice 
The dorsal root ganglia from L4 lumbar region were serially sectioned. Best matched sections shown here in blue and orange 
























Best matched sections of L4 dorsal root ganglia were picked from wildtype, 
heterozygous H304R/+, and homozygous H304R/R male mice for further staining 
with neuronal subpopulation specific makers (Figure 4-11). I successfully 
optimized the working conditions to stain dorsal root ganglia sections with anti-
CGRP antibody to label nociceptive neurons and with anti-Parvalbumin (PV) 
antibody to label the proprioceptive neurons (Figure 4-11). This optimized 
methodology (Table 4-4) can be further used to stain and count the anti-PV 
positive neurons (proprioceptors) and the anti-CGRP positive neurons 
(nociceptors).  




Working concentration Notes  
Mouse anti- βIII tubulin 1:200 
Primary antibody 
dilutions are to be 
prepared in the Block 
buffer prepared with 
Bovine Serum Albumin 
(BSA).  
Overnight incubation at 
4°C. 
Goat anti-CGRP  1:100 
Rabbit anti- parvalbumin 1:100 
   
Secondary antibody 
 
Working concentration Notes 
Donkey anti- mouse 350 1:200 
Goat secondary 
antibody dilutions are to 
be prepared in the Block 
buffer prepared with 
Bovine Serum Albumin 
(BSA). 
3 hours incubation at 
room temperature. 
Donkey anti- goat 488 1:100 
Donkey anti- rabbit 568 1:200 
105 
 
Counting subpopulation numbers of anti-PV positive neurons and anti-CGRP 
positive neurons can be used to calculate and compare the percentage of each 
subpopulation over total neurons present in the DRG of H304R mice. Preliminary 
data for the wildtype DRG is presented in table 4-5. Out of all the βIII tubulin 
stained neurons, ~ 36% of the neurons were anti-PV positive and ~59% of the 
neurons were anti-CGRP positive in the same section of the wildtype DRG. 
 
Table 4-5 Preliminary counts of wildtype DRG subpopulation 
Subpopulation  Counts 
Total cell bodies  39 
anti-PV positive cell bodies 14 
anti-CGRP positive cell bodies 23 
% anti-PV positive cell bodies 35.90% 






Figure 4-11 Neuronal subpopulations staining of dorsal root ganglia 
The dorsal root ganglia section from wildtype mice was stained with anti-βIII tubulin to identify all sensory neurons. The 
section was co-labelled with anti-parvalbumin and anti-CGRP primary antibodies to identify proprioceptive and nociceptive 




Charcot-Marie-Tooth patients exhibit sensory neuropathy symptoms in addition 
to the motor neuropathy symptoms. In parallel, previously published dynein 
heavy chain mutant Loa/+, Cra/+ and Swl/+ mice have also reported sensory 
deficits (Chen et al., 2007; Dupuis et al., 2009). Based on the reports in human 
CMT patients and previously published mutant dynein mice, I initiated the 
sensory phenotype assessments of the H304R mouse model.  
First, I started with characterizing the pain sensitivity response of H304R mice 
with the tail flick test and found that both male and female homozygous H304R/R 
mice had a statistically significant quicker response time to the pain stimulus than 
the wildtype mice at 3 months of age. Male homozygous H304R/R mice also 
showed a statistically significant quicker response time at 12 months of age as 
compared to the wildtype mice. However, due to unavailability of female 
homozygous H304R/R mice, no data was presented for comparison at 12 
months. Heterozygous H304R/+ male mice also showed a quicker response to 
tail flick test but didn’t have any significant differences as compared to the 
wildtype control or homozygous H304R/R littermate mice at multiple time points.  
It was previously reported that the heterozygote Loa/+ mice took a longer time to 
respond to the tail flick test (unpublished data, (Banks and Fisher, 2008)). In 
contrast, the H304R mutant mice took lesser time to respond on the tail flick test. 
These contrasting observations indicate that the H304R mutation in the dynein 
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heavy chain might be affecting nociceptive neurons differently than the Loa 
mutation (F580Y) in the dynein heavy chain.  
Next, a closer examination of sciatic nerve anatomy revealed that homozygous 
H304R/R mice had thinner sciatic nerves as compared to both the wildtype and 
heterozygous H304R/+ littermate mice. Quantitatively homozygous H304R/R 
mice had an overall reduction of ~40% in total fascicular area of its sciatic nerve 
as compared to the wildtype littermates at 3 months and 12 months of age. 
Heterozygous H304R/+ mice displayed a slight 16% reduction in the total 
fascicular area at 3 months and 12 months of age, but this difference was not 
statistically significant as compared to the wildtype littermate control animals.  
Reductions in the sciatic nerve thickness of H304R mice were similar to the 
observations of thinner sciatic nerves in the Loa/+ and Swl/+ mice (unpublished 
data, (Banks and Fisher, 2008)). Repetition of sciatic nerve experiments needs to 
be performed on more number of animals to confirm this preliminary observation. 
Observations of the sciatic nerve appearing thinner and reduction in the total 
fascicular area in the heterozygous H304R/+ and homozygous H304R/R mice 
opened many interesting follow up questions. That is why counting the number of 
axons inside the largest fascicle was the next key step to determine the potential 
reason behind the observed reduction in the total fascicular area. The preliminary 
data from a littermate set revealed that there was a reduction in the number of 
the axons in both the heterozygous H304R/+ (~29%) and homozygous H304R/R 
(47%) mice as compared to the wildtype control. However, the percentage 
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distribution of the bundled axons vs single axons was same in the fascicles from 
all three genotypes. Reduced number of axons could be a potential reason 
behind the thinner sciatic nerves inside the mutant H304R mice; however, further 
investigations are necessary to establish this preliminary observation.  
Because the sciatic nerve is a “mixed nerve”, it receives axons from both the 
dorsal root (sensory neurons) and ventral root (motor neurons) of the spinal 
column. The reduction in the diameter of sciatic nerve could be due to the loss of 
axonal projections from the dorsal root and/or the ventral root. In order to answer 
this question, I picked the sensory route or the dorsal root ganglia (DRG) to study 
further.  
As mentioned previously in this chapter, DRG has a mixed neuronal 
subpopulation of sensory neurons that could be identified for quantitative 
analysis. I successfully optimized the working conditions to label and identify the 
neuronal subpopulation in the DRG of H304R mice. Future experiments using 
these optimized conditions can be used to label all neurons with the βIII-tubulin 
marker, proprioceptive neurons with the parvalbumin marker, and nociceptive 
neurons with the calcitonin gene related protein (CGRP) marker. Next, these 
labelled neuronal subpopulations can be quantitatively analyzed to calculate the 
percentage of proprioceptive or nociceptive subpopulation over all the neurons 
inside a DRG. Preliminary calculations with the wildtype DRG showed that ~36% 
of all neuronal cell bodies were anti-parvalbumin positive cell bodies and nearly 
~59% of all neurons were anti-CGRP positive cell bodies in the same stained 
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section of the DRG. Further quantitative subpopulation comparisons may reveal 
some key differences in the composition of DRG in the three genotypes of the 
H304R mice. 
Overall, my preliminary work to characterize the sensory phenotype of H304R 
mice revealed some interesting differences in the pain sensitivity response and 
sciatic nerve anatomy of mutant heterozygous H304R/+ and homozygous 
H304R/R mice. The sciatic nerve anatomy of mutant heterozygous H304R/+ and 
homozygous H304R/R mice was also comparable with previously published 
dynein mice (Loa/+ & Swl/+) as outlined above. Further in-depth studies with a 
greater number of animals will be required to establish the preliminary 
observation of reduced sciatic nerve thickness in the H304R mice. Subsequent 
studies exploring and comparing the DRG neuronal subpopulations between the 
three genotypes would be needed to get a deeper explanation of the preliminary 
observations in the sensory phenotype of H304R mice.  
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CHAPTER 5: MOTILITY STUDIES OF H304R MICE 
5.1 Introduction and rationale 
Dynein is the key motor protein involved in the retrograde transport of cargoes 
along the neuronal axon (Hirokawa et al., 1990). Direct role of dynein has been 
established in the retrograde transport of neurotrophin mediated trk receptors 
towards the neuronal soma for survival response (Heerssen et al., 2004; Yano et 
al., 2001), fast axonal transport (Waterman-Storer et al., 1997), neurite growth 
and organization (Ahmad et al., 1998), and neuronal migration (Tanaka et al., 
2004). Therefore, it is not surprising that the mutations in dynein have been 
reported to show the impaired axonal transport in the DHC mutant Loa/+ mice 
(Ori-McKenney et al., 2010) and in Swl/+ mice (Zhao et al., 2016).  
Hence, we were also interested in investigating the intracellular motility 
phenotype of H304R mouse model. Because previously studied DHC mutant 
Loa/Loa mice showed defects in the development of its cortical and hippocampal 
regions (Ori-McKenney and Vallee, 2011), we chose neurons from these areas 
for our initial motility studies. We started with isolating cortical and hippocampal 
neurons from H304R embryos (at E16.5) because embryonic neurons are easier 
to grow in vitro than the adult mice neurons. Motility studies with established 
dynein cargoes such as synaptophysin containing synaptic vesicles (Li et al., 
2000) and Rab7 positive vesicles (Johansson et al., 2007) were performed in 




5.2.1 Synaptophysin-RFP positive vesicular motility in hippocampal neurons 
Hippocampal neurons from H304R mice were isolated and plated on coverslips 
for intracellular motility experiments. The neurons from the same genotype were 
pooled together independent of the gender of the embryo. Hippocampal neurons 
were then infected with BacMam synaptophysin-RFP and were imaged at the 
ages DIV 10 and 14 (more details in the methods chapter section 2.5). Various 
parameters such as the number of movements in the inward (towards the cell 
body) and outward (away from the cell body) directions, run length or distance 
(µm), and velocity (µm/sec) were recorded of the synaptophysin-RFP positive 
vesicles that were moving. The data was then analyzed and statistically 
compared between the three genotypes. The wildtype mice are referred as HH, 
the heterozygous mice are referred as HR, and the homozygous mice are 
referred as RR in this chapter. 
At DIV 10, synaptophysin-RFP positive vesicles in homozygous H304R/R mice 
showed an unusual distribution of movement patterns i.e. about 83% of vesicles 
were moving in the inward direction as compared to about 45% of inward 
direction bound vesicles in both the wildtype and heterozygous H304R/+ mice 
(Table 5-1). Subsequently, about 17% of vesicles were outward direction bound 
in the homozygous H304R/R mice as compared to about 55% outward direction 




Table 5-1 Synaptophysin-RFP positive vesicles motility in hippocampal 
neurons at DIV 10 
 
Furthermore, both inward and outward bound synaptophysin-RFP positive 
vesicles in heterozygous H304R/+ mice showed a slight (but insignificant) 
increase in the distance (µm) covered as compared to the wildtype and 
homozygous H304R/R mice (Figure 5-1). Both heterozygous H304R/+ and 
homozygous H304R/R mice showed a slight reduction in the velocity (µm/sec) of 
the inward and outward bound synaptophysin-RFP positive vesicles as 
compared to the wildtype mice, but this reduction was not found to be statistically 




Figure 5-1 Synaptophysin-RFP positive vesicles motility in hippocampal 
neurons at DIV 10 
The graphs show the distance (µm) covered by the vesicles in the inward (A) and 
outward (B) bound directions. The graphs show the velocity (µm/sec) of the vesicles in 
the inward (C) and outward (D) bound directions. Wildtype (black bars), heterozygous 
H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars).  
 
At DIV 14, synaptophysin-RFP positive vesicles in homozygous H304R/R mice 
showed an altered distribution of movement patterns. About 32% of 
Synaptophysin-RFP positive vesicles were moving in inward direction as 
compared to about 50-60% of inward bound vesicles in the wildtype and 





Subsequently, 68% of synaptophysin-RFP positive vesicles were moving in 
outward direction as compared to about 40-50% of outward-bound vesicles in the 
wildtype and heterozygous H304R/+ mice. 
Table 5-2 Synaptophysin-RFP positive vesicles motility in hippocampal 
neurons at DIV 14 
 
Interestingly, synaptophysin-RFP positive vesicles in homozygous H304R/R mice 
displayed a significant increase in the distance covered (µm) as compared to the 
wildtype and heterozygous H304R/+ mice (One-way ANOVA, p<0.05) (Figure 5-
2). Heterozygous H304R/+ mice showed slight but insignificant increase in its 
vesicular distance coverage as compared to the wildtype mice. However, the 
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synaptophysin-RFP positive vesicles in heterozygous H304R/+ mice showed a 
significant decrease in its velocity (µm/sec) as compared to both wildtype and 
homozygous H304R/R mice (One-way ANOVA, p<0.05) (Figure 5-2).   
 
Figure 5-2 Synaptophysin-RFP positive vesicles motility in hippocampal 
neurons at DIV 14 
The graphs show the distance (µm) covered by the vesicles in the inward (A) and 
outward (B) bound directions. The graphs show the velocity (µm/sec) of the vesicles in 
the inward (C) and outward (D) bound directions. Wildtype (black bars), heterozygous 
H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars). Note: * shows 





5.2.2 Synaptophysin-RFP positive vesicular motility in cortical neurons 
Cortical neurons from H304R mice were isolated and plated on coverslips for 
intracellular motility experiments. The neurons from the same genotype were 
pooled together independent of the gender of the embryo. Cortical neurons were 
then infected with BacMam synaptophysin-RFP and were imaged at the ages 
DIV 10 and 14. Various parameters such as the number of movements in the 
inward (towards the cell body) and outward (away from the cell body) directions, 
run length or distance (µm), and velocity (µm/sec) were recorded of the 
synaptophysin-RFP positive vesicles that were moving. The data was then 
analyzed and statistically compared between the three genotypes. 
At DIV 10, synaptophysin-RFP positive vesicles in both heterozygous H304R/+ 
and homozygous H304R/R mice showed an altered distribution of movement 
patterns. About 63% of the vesicles in H304R mutant mice were moving in the 
inward direction as compared to about 82% of inward direction bound vesicles in 
the wildtype mice (Table 5-3). Subsequently, about 40% of vesicles were 
outward direction bound in both heterozygous H304R/+ and homozygous 







Table 5-3 Synaptophysin-RFP positive vesicles motility in cortical neurons 
at DIV 10 
 
Furthermore, both inward and outward bound synaptophysin-RFP positive 
vesicles in heterozygous H304R/+ and homozygous H304R/R mice showed an 
alteration in the distance (µm) covered as compared to the wildtype, but this 
alteration was not significantly different statistically (Figure 5-3). Heterozygous 
H304R/+ mice showed a slight (but insignificant) increase in the velocity (µm/sec) 
of the inward and outward bound synaptophysin-RFP positive vesicles as 




Figure 5-3 Synaptophysin-RFP positive vesicles motility in cortical neurons 
at DIV 10 
The graphs show the distance (µm) covered by the vesicles in the inward (A) and 
outward (B) bound directions. The bottom graphs show the velocity (µm/sec) of the 
vesicles in the inward (C) and outward (D) bound directions. Wildtype (black bars), 
heterozygous H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars).  
 
At DIV 14, synaptophysin-RFP positive vesicles showed a similar distribution of 
movement patterns in all 3 genotypes. About 50-60% of the vesicles in H304R 
mice was moving in the inward direction and about 40-50% of the vesicles were 





Table 5-4 Synaptophysin-RFP positive vesicles motility in cortical neurons 
at DIV 14 
 
 
Both inward and outward bound synaptophysin-RFP positive vesicles had similar 
distance (µm) covered in all 3 genotypes as well (Figure 5-4). Heterozygous 
H304R/+ mice showed a peculiar pattern in the velocity (µm/sec) characteristic of 
the inward and outward bound synaptophysin-RFP positive vesicles as 
compared to the wildtype and homozygous H304R/R mice (Figure 5-4). Velocity 
of synaptophysin-RFP positive vesicles was decreased in the inward bound 
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direction and increased in the outward bound direction as compared to both the 
wildtype and homozygous H304R/R mice, but this difference was not statistically 
significant (Figure 5-4).  
 
Figure 5-4 Synaptophysin-RFP positive vesicles motility in cortical neurons 
at DIV 14 
The graphs show the distance (µm) covered by the vesicles in the inward (A) and 
outward (B) bound directions. The bottom graphs show the velocity (µm/sec) of the 
vesicles in the inward (C) and outward (D) bound directions. Wildtype (black bars), 






5.2.3 Rab7-GFP positive vesicular motility in cortical neurons 
Cortical neurons from H304R mice were isolated and plated on coverslips for 
intracellular motility experiments. The neurons from the same genotype were 
pooled together independent of the gender of the embryo. Cortical neurons were 
nucleofected with Rab7-GFP and were imaged at the age DIV 10. Various 
parameters such as the number of movements in the inward (towards the cell 
body) and outward (away from the cell body) directions, run length or distance 
(µm), and velocity (µm/sec) were recorded of the synaptophysin-RFP positive 
vesicles that were moving. The data was then analyzed and statistically 
compared between the three genotypes. 
At DIV 10, Rab7-GFP positive vesicles in both heterozygous H304R/+ and 
homozygous H304R/R mice showed a similar distribution of movement patterns 
in both inward and outward directions as compared to the wildtype mice (Table 5-
5). The Rab7-GFP positive vesicles in homozygous H304R/R mice showed an 
increase in the distance (µm) covered by them in the inward direction, but this 
difference was not significant compared to the wildtype and heterozygous 












Figure 5-5 Rab7-GFP positive vesicles motility in cortical neurons at DIV 10 
The graphs show the distance (µm) covered by the vesicles in the inward (A) and 
outward (B) bound directions. The bottom graphs show the velocity (µm/sec) of the 
vesicles in the inward (C) and outward (D) bound directions. Wildtype (black bars), 
heterozygous H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars). 
Note: * shows statistical significance (1-way ANOVA, p<0.05). 
 
The outward bound Rab7-GFP positive vesicles in heterozygous H304R/+ 
showed a significant increase in the distance (µm) covered as compared to the 
wildtype and homozygous H304R/R mice (One-way ANOVA, p<0.05) (Figure 5-
5). The velocities of both inward and outward bound Rab7-GFP vesicles were 






The preliminary motility studies with synaptophysin-RFP and Rab7-GFP positive 
vesicles in the hippocampal and cortical primary neurons from the H304R mice 
presented highly variable and sometimes contradictory results. There could be 
multiple reasons behind these variable results, such as: 
 Pooling of the primary neurons from the male and female embryos 
together for each genotype might have masked any motility differences, 
especially in the heterozygous H304R/+ mice neuronal cultures. We 
previously showed that the male heterozygous H304R/+ mice are affected 
more than the female heterozygous H304R/+ mice in their motor skills 
phenotype. A better approach would be to perform the motility studies on 
primary neuron cultures that are grown separately based on the genotype 
and gender of the embryos. 
 The primary neurons were collected from the E16.5 developing embryos 
that are hard to isolate and grow consistently in vitro. 
 The motility videos were collected from the longest visible axonal 
projection in culture for the data analysis. The classification of “inward” 
and “outward” direction bound moving vesicles may not be accurate if the 
longest visible axonal projection was not an axon. Only the axons are 
known to have an established microtubule polarity and the dendrites have 
microtubules arranged in a random fashion with mixed polarities. Hence, 
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this could have introduced another source of variability in the direction 
based motility data comparison. 
 The motility analysis was done on the primary neurons that were grown in 
vitro for 10 (DIV 10) or 14 (DIV 14) days. Performing motility analysis at a 
range of early and late time points might reveal some alterations in the 
motility phenotype. 
In conclusion, performing future motility experiments with the abovementioned 
considerations might help resolve the variability issue observed in the preliminary 
study results. Additionally, at the time of this preliminary study we chose neurons 
from the central nervous system (CNS) due to the established experimental 
protocols in CNS neurons. Future motility studies should also be performed on 







CHAPTER 6: DISCUSSION 
6.1 All dynein mutations don’t act the same 
The motor protein dynein is responsible for retrograde transport of crucial 
cargoes from the axonal tip to the soma in neurons. Various studies show the 
specific role of dynein in neuronal functions such axonal transport (He et al., 
2005), retrograde signaling (Perlson et al., 2009), protein degradation and 
recycling (Ligon et al., 2005), and neuronal migration (Ori-McKenney and Vallee, 
2011). It is evident that neurons need a robust retrograde mediated transport for 
its growth, maintenance, and survival. Hence, it is not surprising to see that 
several mutations in cytoplasmic dynein have been reported in human 
neurodegenerative diseases. These dynein mutations (Table 1-2) are associated 
with motor and sensory neuropathies such as Charcot-Marie-Tooth type 2O 
(CMT2O) (Weedon et al., 2011), Spinal Muscular Atrophy with Lower Extremity 
Dominant (SMA-LED) (Harms et al., 2012) (Tsurusaki et al., 2012), in 
malformations of cortical development (MCD) (Poirier et al., 2013), in intellectual 
disability (Willemsen et al., 2012), and congenital cataract and gut dysmotility 
(Gelineau-Morel et al., 2016).  
The spectrum of neurodegenerative diseases in humans point out the 
susceptibility of neurons to the dynein mutations in the peripheral and central 
nervous systems. Perhaps, it is the distinct structure and function of neurons that 
make them very sensitive to the altered functions of mutant dynein. For example, 
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the motor neurons have very long axons that can grow up to a meter in humans 
and require robust axonal transport for its maintenance (Levy and Holzbaur, 
2006). Not surprisingly, about 18 distinct mutations in dynein heavy chain are 
reported thus far in SMA-LED patients with peripheral motor neuron loss (Scoto 
et al., 2015). The same study also reported about 16 mutations in dynein heavy 
chain associated with malformations of cortical development (MCD), signifying 
the vulnerability of neurons in the central nervous system to the mutant dynein 
functions.  
The dynein heavy chain (DHC) mutations in motor domain and tail domain alter 
the dynein function differentially, thus giving rise to a spectrum of human 
neuropathies spanning both the peripheral and central nervous systems in 
humans (Scoto et al., 2015). Interestingly, the same DHC mutation can cause 
two different diseases as well. For examples, the H306R mutation in DHC is 
associated with both CMT2O (Weedon et al., 2011) and SMA-LED (Tsurusaki et 
al., 2012). In fact, both CMT2O and SMA-LED patients exhibit similar clinical 
symptoms such as muscle weakness and wasting in legs, developmental 
milestone delays, skeletal deformities, joint contractures, and gait problems. The 
only difference is that the CMT2O patients also exhibit sensory loss symptoms, in 
addition to the motor deficits.  
Various mutations exist in the DHC peptide with overlapping phenotypes, but 
they all do not cause just one exact same neuropathy in humans. Rather these 
DHC mutations cause different type of neuropathies, thus signaling that the 
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mutations alter proteins in different ways. Our previous studies with filamentous 
fungi N.crassa also recapitulated similar observations where various dynein 
mutations resulted in distinct fungal morphology and vesicular motility 
(Sivagurunathan et al., 2012). Because different dynein mutations do not behave 
the same and cause the same phenotype in humans, there is a possibility that 
there might be a distinct molecular mechanism of disease behind each dynein 
mutation.  
6.2 Relevance of H304R Mouse Model 
Relevance of heterozygous H304R/+ mice 
One key feature of Charcot-Marie-Tooth type 2O (CMT2O) disease is the 
heterogeneity of its onset and the severity of the clinical symptoms in patients. 
Family members with the same CMT2O dynein mutation reported variable ages 
of onset and the severity of the clinical symptoms expressed. Similar trends were 
observed in our study with the heterozygous H304R/+ mice behavioral and 
phenotypic characteristics. The heterozygous H304R/+ mice showed variable 
onset of phenotype, i.e. early onset of reduced all limbs grip strength and rotorod 
test defects, while late onset of reduced front grip strength and tail suspension 
reflex. Some heterozygous H304R/+ mice expressed a mild phenotype, whereas 
some expressed a more severe phenotype just like as seen in the human 
patients with the corresponding autosomal dominant CMT2O mutation. 
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A possible explanation to this heterogeneity might lie in the fact that dynein 
heavy chains (DHC) dimerize with each other and interact with other subunits 
(like intermediate chains, light intermediate chain, & light chains) to form a 
functional dynein motor complex. In the heterozygous H304R/+ mice, there 
would be a mix of DHC monomers that have been translated from the 
heterozygous DHC alleles (H304R/+). From the mix of wildtype and H304R 
mutant DHC monomers, three possible combinations of dynein population may 
arise – 
 A quarter population of dynein containing wildtype DHC dimers only 
 A quarter population of dynein containing mutant DHC dimers only 
 And half of the population of dynein containing DHC dimers of 1 wildtype 
monomer dimerized with 1 mutant DHC monomer  
Thus, at any given time, a heterozygous H304R/+ mouse cells will have all three 
types of DHC dimers combination – wildtype, homozygous, and heterozygous 
DHC dimers. There could be a “dose-dependent” modulation of dynein motor 
function depending on what percentage of wildtype, homozygous, and 
heterozygous DHC dimers are present and interacting functionally with other 
dynein subunits at a given time. The variable level of DHC dimers may also affect 
the interaction of the dynein motor complex with its other binding partners and/or 
cargoes. Future biochemical tests with purified dynein from H304R mouse model 
can reveal key insights on the cellular dynamics that happen when different 
“doses” of wildtype, homozygous, heterozygous DHC dimers are around in a cell. 
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One key experiment will be to test the binding efficiency of wildtype, 
homozygous, and heterozygous DHC dimers with other dynein subunits and key 
binding partners of dynein such as dynactin, BicD, Lis1, Nudel etc.. 
Another key observation in the heterozygous H304R/+ mice was the gender-
based differences in the exhibition of the motor skills phenotypic defects. Overall, 
the male heterozygous H304R/+ mice appeared to be more affected by the 
dynein mutation as evident in the various motor-skills assays. In contrast, the 
female heterozygous H304R/+ mice showed mild to no defects in the exhibition 
of the motor skills phenotypic defects. A potential reason behind this gender-
based observation could be the presence of the neuroprotective effects of 
estrogen in the female mice (Green and Simpkins 2000). Thus, the female 
heterozygous H304R/+ mice appear to be less sensitive to the effects of the 
dynein mutation on their motor skills phenotype. Similar observations were made 
in a small study with CMT1A patients where the male patients were shown to 
have significantly reduced muscle strength in their lower limbs as compared to 
the female patients (Wozniak and Gess, 2015). 
Relevance of homozygous H304R/R mice 
The homozygous H304R/R mice exhibited severe symptoms of atypical tail 
suspension, reduced grip strength and rotorod deficits right from an early age. 
The onset and the severity of homozygous H304R/R phenotype recapitulated the 
severity of SMA-LED symptoms as seen in another and the only reported 
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homozygous DHC mutation (R399G) (Scoto et al., 2015). Offspring with this 
DHC homozygous R399G mutation showed an early onset and severe motor 
symptoms as compared to the parents that were heterozygous for the same DHC 
mutation. 
Furthermore, both male and female homozygous H304R/R mice showed similar 
trends of deficiencies in their behavioral phenotype, unlike the heterozygous 
H304R/+ mice that showed gender-based deficiencies in their phenotype 
(Sabblah et al., 2018). As in the previous publication, only the male heterozygous 
H304R/+ mice primarily exhibited an altered motor skills phenotype in most 
behavioral tests. The female heterozygous H304R/+ mice exhibited little to no 
difference in its behavioral phenotype as compared to the wildtype mice. This key 
difference between the heterozygous H304R/+ and homozygous H304R/R mice 
indicates that the homozygous H304R/R mutation has a distinct and more severe 
effect on the dynein function that may not altered by the gender differences of the 
mice.  
Overall relevance of H304R mice in understanding the dynein function 
In conclusion, both heterozygous H304R/+ and homozygous H304R/R mice with 
DHC mutations recapitulate the onset and the phenotypes as seen with the 
reported heterozygous (H306R) and homozygous (R399G) dynein mutations in 
humans. Hence, our H304R mouse model would serve as a relevant and useful 
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mouse model to understand the molecular mechanism of mutant dynein in 
human neuropathies.  
6.3 Comparison of H304R Mouse Model with Other Dynein Mouse Models 
Previously reported mutant DHC mice were generated using ENU or radiation 
based mutagenesis method that exhibited dominant neurological phenotypes 
(Hrabe de Angelis et al., 2000) (Duchen, 1974). The mutant DHC mice were 
Legs at odd angle (Loa) mice with F580Y mutation, Cramping (Cra) mice with 
Y1055C mutation, and Sprawling (Swl) mice with a nine base-pair deletion 
[GIVT]1040[A] mutation in the cytoplasmic dynein heavy chain gene. Even 
though all three mutations were located in the tail domain of the dynein heavy 
chain, the Loa, Cra and Swl did not display the same exact phenotype.  
A key difference is that the H304R mouse model has the corresponding dynein 
mutation (H306R) that is reported to cause neuropathies in humans (CMT2O and 
SMA-LED) (Tsurusaki et al., 2012; Weedon et al., 2011). In contrast, the 
mutagenesis generated Loa, Cra, and Swl mice models do not have a 
corresponding mutation that is associated with any human neuropathies. Hence, 
it is hard to correlate their findings as a basis for human neuropathy. Another key 
difference between H304R mice and other DHC mice is that homozygous 
Loa/Loa, Cra/Cra, and Swl/Swl were embryonically lethal or did not survive 24 
hours post birth due to inability to move and feed (Hafezparast et al., 2003) 
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(Zhao et al., 2016). In contrast, the homozygous H304R/R mice survived post 
birth and had a normal lifespan.  
The H304R mouse model shares many commonalities with other published 
models of dynein heavy chain mutation Loa, Cra, and Swl. The first commonality 
is that all the mutations are located in the tail domain of the dynein heavy chain. 
Shared phenotypes between H304R model and Loa/+, Cra/+ and Swl/+ mice are 
– atypical reflex of clenching hind limbs closer to the body upon tail suspension, 
normal life span, gait abnormalities, reduced grip strength in hind limbs, and 
thinner sciatic nerves. Additionally, H304R/+ and H304R/R mice showed deficits 
in rotarod performance similar to Loa/+ mice.  
In conclusion, the H304R model and previously published DHC mice model 
display a varying range of phenotypes. The severity of the mouse DHC mutations 
on the dynein function varies in the following order – the homozygous Loa/Loa, 
Cra/Cra and Swl/Swl are the most severe mutations, followed by the 
homozygous H304R/R and heterozygous Loa/+, Cra/+ and Swl/+ moderate 









Figure 6-1 Severity of phenotypes associated with DHC mutations 
Comparison of the severity of mouse DHC mutations with the human DHC mutations. The severity of the 


























6.4 Future Sensory Characterization Work of H304R Mouse Model 
Collectively behavioral assessments like tail suspension, grip strength, and 
rotarod performance tests have given us some robust insights into the motor 
phenotype of H304R mouse model. Neuromuscular junction (NMJ) analysis gave 
additional evidence supporting the defective motor phenotype of H304R mouse 
model (Sabblah et al., 2018). NMJ analysis revealed the deficiencies in the 
morphology and complexity in heterozygous H304R/+ and homozygous 
H304R/R male mice. The synaptophysin occupancy in NMJs were also found to 
be faulty, indicating a loss of motor neuron functionality in heterozygous H304R/+ 
and homozygous H304R/R male mice. The reason why the motor neurons are 
not functional in mutant H304R mice is yet to be explored.  
However, investigating the motor characterization is only one part of the equation 
in understanding a motor-sensory neuropathy like CMT2O. Multiple studies have 
indicated dynein’s role in sensory neuron maintenance and survival (Deinhardt et 
al. (2006); (Saxena et al., 2005; Yano et al., 2001). In parallel, the previously 
published dynein heavy chain mutant Loa/+, Cra/+ and Swl/+ mice have also 
reported sensory deficits. Heterozygote Loa/+ and Swl/+ mice reportedly had 
reduced size of dorsal root and fewer neurons in their lumbar dorsal root ganglia 
(Chen et al., 2007). Furthermore, Loa/+ and Swl/+ also showed abnormal 
proprioceptive phenotype as indicated by the absence of H-reflex and specific 
loss of proprioceptive sensory neurons as compared to the wildtype mice. 
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Interestingly, Loa/+ and Swl/+ mice also had thinner sciatic nerves as compared 
to the wildtype control mice. The Swl/+ mice showed no difference in the latency 
to tail withdrawal as compared to the wildtype control mice. The Cra/+ mice 
displayed subtler sensory phenotype than the Loa/+ and Swl/+ mice and had 
reduced size of its dorsal root due to the loss of large caliber axon (potentially 
proprioceptive) neurons (Dupuis et al. (2009). In conclusion, CMT2O patients 
and all the other dynein mutant mice (Loa/+, Cra/+, and Swl/+) showed mild to 
severe sensory phenotype and subsequently raised a question on the sensory 
phenotype of the H304R mouse model. Hence, I started investigating the 
sensory phenotype of H304R mice with tail flick test, sciatic nerve thickness 
measurements, and optimizing the protocol to identify the dorsal root ganglia 
neuronal subpopulation. 
Preliminary results from the tail flick tests showed a quicker latency to tail 
withdrawal from the pain stimulus in the homozygous H304R/R mice. One 
possible explanation is that the homozygous H304R/R mice have hypersensitivity 
to thermal pain stimulus due to reduced pain threshold as commonly seen in 
mice models with sciatic nerve injury and persistent sensory neuropathic pain 
(Wang et al., 2009; Yajima et al., 2002). Incidentally, severely affected CMT2O 
patients also reported having neuropathic pain (Weedon et al., 2011).  
Next, a closer examination of peripheral nervous system revealed thinner sciatic 
nerves and reduced axonal counts in both the heterozygous H304R/+ and 
homozygous H304R/R mice. It would be interesting to learn if the sciatic nerve 
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thinning in homozygous H304R/R is caused by the loss of motor and/or sensory 
neurons. One way to test this would be to stain the sciatic nerve cross sections 
with unique markers for both motor and sensory neurons. Then the number of 
motor and sensory axons passing through the sciatic nerve can be counted and 
normalized against the total number of neurons (labeled with a pan-neuronal 
marker). This would help in identifying if any alteration in the number of motor 
and/or sensory neurons led to thinner sciatic nerve in homozygous H304R/R 
mutant mice.  
To advance the sensory characterization, it would be of critical importance to 
identify the neuronal subpopulation inside the dorsal root ganglia (DRG) as well 
of the H304R mouse model. Previous work on Swl/+ mice revealed a significant 
loss of proprioceptive neurons in the lumbar DRG (Chen et al., 2007). My 
optimization work established the working protocol of how to stain and identify 
nociceptive and proprioceptive subpopulations in the same section of the DRG of 
H304R mice. The next step would be to stain DRG sections from the wildtype, 
heterozygous H304R/+, and homozygous H304R/R mice with the unique 
markers for each neuronal subpopulation. Then the number of neuronal cells 
positive for nociceptive marker or proprioceptive marker can be counted and 
normalized over the total count of neurons in the DRG. The results would yield if 
there are any differences in the neuronal subpopulations count in the H304R 




6.5 Potential Dynein Disruptions in the H304R Mice and Future Studies 
Our preliminary studies revealed both motor and sensory defects in our H304R 
mouse model. Because large sized motor and sensory neurons have high 
demands for energy and require robust axonal transport, it is not surprising that 
motor and sensory neurons are vulnerable to the mutations that may alter the 
dynein functions in retrograde axonal transports (LaMonte et al., 2002; Ori-
McKenney et al., 2010). Dynein has an established role in transporting nerve 
growth factors via activated trk signaling from the neuronal tip to the soma for 
neuronal survival (Heerssen et al., 2004; Mitchell et al., 2012; Yano et al., 2001). 
Impaired retrograde signaling of growth factors or neurotropic factors in sensory 
neurons has been shown to develop peripheral neuropathy phenotypes in mice 
(Rishal et al., 2012). Based on this literature evidence, I speculate three different 
potential mechanism of the H304R mutation in the disease progression. 
The first disease mechanism is that the dynein mutation affects the retrograde 
signaling of endosomes with the neurotrophic factors. This would lead to a loss of 
sensory neurons in the H304R mice. As evident from my preliminary work with 
the sensory phenotype characterization, I think the nociceptive (pain sensing) 
subpopulation of the sensory neurons might be affected more as seen in the 
quick tail withdrawal latency in the mutant H304R mice. Hence, impaired 
retrograde signaling leading to the loss of nociceptive sensory neurons ultimately 
causes the altered sensory phenotypes such as altered tail withdrawal, thinner 
sciatic nerves, and a loss of axonal counts in the heterozygous H304R/+ and 
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homozygous H304R/R mice. Investigating the robustness of retrograde signaling 
of trk receptors upon activation of growth factors such as brain derived 
neurotrophic factors (BDNF), nerve growth factor (NGF), or neurotrophins (NTs) 
would be of critical importance in understanding the role of mutant dynein in the 
H304R mice. 
The second disease mechanism is the impaired retrograde transport of length 
sensing cellular factors leading to an altered growth of sensory neurons. This is 
based on an interesting study that revealed a role of dynein in maintaining the 
sensory neurons length (Ori-McKenney et al., 2010). In this study, adult sensory 
neurons in the heterozygote Loa/+ mice had longer neurites than the wildtype 
controls when grown in vitro. Additionally, heterozygote Loa/+ mice showed a 
similar trend of significantly longer axis from cell periphery to the nucleus in 
embryonic fibroblasts as compared to wildtype controls. These results indicated 
that dynein might have a role in transporting the length sensing cellular factors 
needed for sensory neuron axonal length maintenance. Based on the evidence 
presented above I speculate that the H304R mice may have an impaired 
retrograde transport of length sensing cellular factors. And that this may lead to 
an alteration in the sensory neuron lengths. Hence, it would be an exciting idea 
to measure and compare the lengths of the sensory neurons in vitro from the 
H304R mice to reveal any alterations in the sensory neuron lengths.  
Lastly, the third possible mechanism for the dynein dysfunction in the H304R 
mice could be a biochemical interaction defect based on the location of the 
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H304R mutation on the dynein heavy chain (DHC) peptide. The H304R mutation 
is located in the tail domain of the DHC peptide. The H304R mutation lies within 
the homodimerization region of the tail domain in the DHC. The presence of the 
H304R mutation in the homodimerization region may cause a hindrance to the 
binding of two DHC monomers to form a functional DHC dimer. The H304R 
mutation could also contribute to interference in the interactions of the DHC to 
other dynein subunits like dynein intermediate chains (DICs) and dynein light 
chains (DLCs). The interactions with DICs and DLCs allow for the indirect 
interaction of the DHCs to its binding factors such as dynactin, Lis1, BicD and 
these binding factors have been implicated in the proper functioning of the 
neurons such as neurofilament transport, clearance of misfolded proteins, and 
neuronal migration. Thus, it would be insightful to perform future studies to 
investigate the functional binding of the mutant DHC with other dynein subunits 
and binding factors using biochemical assays. These biochemical assays may 
potentially uncover any altered dynein interaction that may contribute to the 
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Dynein is an essential motor protein required for the maintenance and survival of the 
cells. Dynein forms a motor complex to carry intracellular cargoes like organelles, 
growth factors, peptides, hormones etc. along the microtubules inside the cells. In 
neurons, the dynein is the retrograde motor protein that moves cargoes from the neuronal 
tip to the neuronal soma along the length of an axon. Dynein has an established role in 
the neuronal nuclei migration, transport of neuronal survival signals and growth factors, 
organelle positioning inside neurons etc. Hence, it is not very surprising that numerous 
mutations in dynein have been reported in association with neurodegenerative diseases in 
humans. The first mutation (H306R) in dynein heavy chain was reported to cause 
Charcot-Marie-Tooth Type 2O disease (CMT2O) in humans. CMT2O patients display 
motor-sensory neuropathy symptoms such as muscle weaknesses and wasting in legs, 
skeletal deformities like pes cavus (high foot arching), difficulty in walking, and a loss of 
sensation. 
We developed a novel knock-in H304R mouse model with the corresponding CMT2O 
linked dynein mutation to understand the disease’s molecular mechanism. We 
investigated and characterized the motor-sensory phenotype of the H304R mouse model 
(wildtype, heterozygous (H304R/+) and homozygous (H304R/R) mice). First, we started 
with testing mice on motor skills behavior tests such as tail suspension reflex, grip 
strength test, and rotarod test at 3, 6, 9 and 12 months of age. Both male and female 
groups of heterozygous (H304R/+) mice displayed mild defects in tail suspension reflex, 
grip strength, and rotarod performance at a later age time point. In contrast, homozygous 
(H304R/R) mice exhibited severe defects in the tail suspension reflex, grip strength, and 
rotarod performance right from an early age. Next, I analyzed the sensory phenotype of 
the H304R mouse model. Homozygous H304R/R mice appeared to have thinner sciatic 
nerve, reduced total fascicular area of the sciatic nerve, and significantly quicker latency 
to tail withdrawal from a pain stimulus.  
Collectively, our motor and sensory characterization studies reveal that H304R dynein 
mouse model recapitulates the phenotype associated with CMT symptoms. Hence, the 
H304R model is a useful tool in understanding the dynein function in the onset and 
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